価格表

在庫・価格 : 2025年04月27日 22時48分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Albumin, Rat Urine, ELISA Kit, Nephrat II
データシート
NR002 EXOエクソセル
EXOCELL Division of Ethos Biosciences, Inc.
1 kit ¥245,000
(未発注)
追加

在庫・価格 : 2025年04月27日 22時48分 現在

Albumin, Rat Urine, ELISA Kit, Nephrat II

  • 商品コード:NR002
  • メーカー:EXO
  • 包装:1kit
  • 価格: ¥245,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Venkatesha S et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 2006 Jun;12(6):642-9
Venkatesha S et al
2006/01/01
PubMed
2 Shimazaki T et al. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology 2002 Jan;35(1):199-208
Shimazaki T et al
2002/01/01
PubMed
3 Choi WI et al. Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 2003 Jun;167(12):1627-32
Choi WI et al
2003/01/01
PubMed
4 Little MA et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005 Sep;106(6):2050-8
Little MA et al
2005/01/01
PubMed
5 Koura T et al. Investigation of albumin-synthesizing ability in rat cirrhotic liver-derived hepatocytes using primary hepatocyte culture. J. Hepatol. 1999 Aug;31(2):293-9
Koura T et al
1999/01/01
PubMed
6 Holwerda KM et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J. Am. Soc. Nephrol. 2014 Apr;25(4):717-25
Holwerda KM et al
2014/01/01
PubMed
7 Nakano D et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J. Am. Soc. Nephrol. 2012 Nov;23(11):1847-56
Nakano D et al
2012/01/01
PubMed
8 Salmon AH et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J. Am. Soc. Nephrol. 2012 Aug;23(8):1339-50
Salmon AH et al
2012/01/01
PubMed
9 Vassiliadis J et al. Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling. J. Am. Soc. Nephrol. 2011 Aug;22(8):1453-61
Vassiliadis J et al
2011/01/01
PubMed
10 Shcheglova T et al. Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy. J. Am. Soc. Nephrol. 2009 May;20(5):1012-9
Shcheglova T et al
2009/01/01
PubMed
11 Russo LM et al. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 2009 Mar;20(3):489-94
Russo LM et al
2009/01/01
PubMed
12 Kim JJ et al. Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J. Am. Soc. Nephrol. 2007 Aug;18(8):2303-10
Kim JJ et al
2007/01/01
PubMed
13 M旦ller CC et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J. Am. Soc. Nephrol. 2007 Jan;18(1):29-36
M旦ller CC et al
2007/01/01
PubMed
14 Ostendorf T et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 2006 Apr;17(4):1054-62
Ostendorf T et al
2006/01/01
PubMed
15 Little MA et al. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 2006 Jan;17(1):160-9
Little MA et al
2006/01/01
PubMed
16 Zhao X et al. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J. Am. Soc. Nephrol. 2004 May;15(5):1244-53
Zhao X et al
2004/01/01
PubMed
17 Kang SW et al. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J. Am. Soc. Nephrol. 2003 Dec;14(12):3178-87
Kang SW et al
2003/01/01
PubMed
18 Ostendorf T et al. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2003 Sep;14(9):2237-47
Ostendorf T et al
2003/01/01
PubMed
19 Lee GT et al. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J. Am. Soc. Nephrol. 2003 Mar;14(3):709-20
Lee GT et al
2003/01/01
PubMed
20 Suga S et al. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms. J. Am. Soc. Nephrol. 2003 Feb;14(2):397-406
Suga S et al
2003/01/01
PubMed
21 de Vriese AS et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 2001 May;12(5):993-1000
de Vriese AS et al
2001/01/01
PubMed
22 Seto M et al. Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis. J. Am. Soc. Nephrol. 1998 Aug;9(8):1367-76
Seto M et al
1998/01/01
PubMed
23 Morita Y et al. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J. Am. Soc. Nephrol. 1997 Sep;8(9):1363-72
Morita Y et al
1997/01/01
PubMed
24 Vora JP et al. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J. Am. Soc. Nephrol. 1996 Jan;7(1):113-7
Vora JP et al
1996/01/01
PubMed
25 Moskowitz DW et al. Effect of epidermal growth factor in the rat 5/6 renal ablation model. J. Am. Soc. Nephrol. 1992 Nov;3(5):1113-8
Moskowitz DW et al
1992/01/01
PubMed
26 Tagawa A et al. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Diabetes 2016 Mar;65(3):755-67
Tagawa A et al
2016/01/01
PubMed
27 Ibrahim AS et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 2011 Apr;60(4):1122-33
Ibrahim AS et al
2011/01/01
PubMed
28 Takiyama Y et al. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism. Diabetes 2011 Mar;60(3):981-92
Takiyama Y et al
2011/01/01
PubMed
29 Scalia R et al. Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain. Diabetes 2007 Jul;56(7):1842-9
Scalia R et al
2007/01/01
PubMed
30 Russo LM et al. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 2007 Feb;56(2):380-8
Russo LM et al
2007/01/01
PubMed
31 Isshiki K et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 2000 Jun;49(6):1022-32
Isshiki K et al
2000/01/01
PubMed
32 Dooley D et al. Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis. Kidney Int. 2018 11;94(5):926-936
Dooley D et al
2018/01/01
PubMed
33 Desideri S et al. A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli. Kidney Int. 2018 05;93(5):1086-1097
Desideri S et al
2018/01/01
PubMed
34 Burlaka I et al. Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease. Kidney Int. 2016 07;90(1):135-48
Burlaka I et al
2016/01/01
PubMed
35 Cassis P et al. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int. 2012 May;81(9):903-18
Cassis P et al
2012/01/01
PubMed
36 Komers R et al. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int. 2011 Feb;79(4):432-42
Komers R et al
2011/01/01
PubMed
37 Lee SC et al. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int. 2009 Oct;76(8):838-48
Lee SC et al
2009/01/01
PubMed
38 Zhou H et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008 Sep;74(5):613-21
Zhou H et al
2008/01/01
PubMed
39 Tao Y et al. VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int. 2007 Dec;72(11):1358-66
Tao Y et al
2007/01/01
PubMed
40 Yoo TH et al. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 2007 May;71(10):1019-27
Yoo TH et al
2007/01/01
PubMed
41 Riazi S et al. 17-beta Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters. Kidney Int. 2006 Feb;69(3):471-80
Riazi S et al
2006/01/01
PubMed
42 Dai T et al. Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int. 2006 Mar;69(5):806-14
Dai T et al
2006/01/01
PubMed
43 Bhatti F et al. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005 Apr;67(4):1371-80
Bhatti F et al
2005/01/01
PubMed
44 Milovanceva-Popovska M et al. R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury. Kidney Int. 2005 Apr;67(4):1362-70
Milovanceva-Popovska M et al
2005/01/01
PubMed
45 Xu ZG et al. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int. 2005 Mar;67(3):944-52
Xu ZG et al
2005/01/01
PubMed
46 Horiba N et al. Gene expression variance based on random sequencing in rat remnant kidney. Kidney Int. 2004 Jul;66(1):29-45
Horiba N et al
2004/01/01
PubMed
47 Kalantarinia K et al. Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 2003 Oct;64(4):1208-13
Kalantarinia K et al
2003/01/01
PubMed
48 Riser BL et al. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int. 2003 Aug;64(2):451-8
Riser BL et al
2003/01/01
PubMed
49 Blasi ER et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003 May;63(5):1791-800
Blasi ER et al
2003/01/01
PubMed
50 Ji L et al. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int. 2002 Aug;62(2):514-24
Ji L et al
2002/01/01
PubMed
51 Braun C et al. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat. Kidney Int. 2002 Jun;61(6):2149-56
Braun C et al
2002/01/01
PubMed
52 Tofovic SP et al. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats. Kidney Int. 2002 Apr;61(4):1433-44
Tofovic SP et al
2002/01/01
PubMed
53 Takeuchi A et al. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate. Kidney Int. 2001 Sep;60(3):1058-68
Takeuchi A et al
2001/01/01
PubMed
54 Kang SW et al. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int. 2001 Apr;59(4):1354-62
Kang SW et al
2001/01/01
PubMed
55 Richards RJ et al. Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats. Kidney Int. 2001 Jan;59(1):37-43
Richards RJ et al
2001/01/01
PubMed
56 Hirschberg R et al. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 1993 Feb;43(2):387-97
Hirschberg R et al
1993/01/01
PubMed
57 Xu Q et al. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension 2008 Apr;51(4):1218-24
Xu Q et al
2008/01/01
PubMed
58 Li Z et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 2007 Oct;50(4):686-92
Li Z et al
2007/01/01
PubMed
59 Elmarakby AA et al. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 2006 Mar;47(3):557-62
Elmarakby AA et al
2006/01/01
PubMed
60 Zhao X et al. Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension 2003 Oct;42(4):775-80
Zhao X et al
2003/01/01
PubMed
61 Matsuoka H et al. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994 Jun;23(6 Pt 2):971-5
Matsuoka H et al
1994/01/01
PubMed
62 Saleh MA et al. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Diabetologia 2011 Apr;54(4):979-88
Saleh MA et al
2011/01/01
PubMed
63 Kuwabara A et al. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010 Sep;53(9):2056-65
Kuwabara A et al
2010/01/01
PubMed
64 Figarola JL et al. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia 2008 May;51(5):882-91
Figarola JL et al
2008/01/01
PubMed
65 Ota T et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia 2003 Jun;46(6):843-51
Ota T et al
2003/01/01
PubMed
66 Clayton AM et al. Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy. Brain Behav. Immun. 2018 05;70:376-389
Clayton AM et al
2018/01/01
PubMed
67 Yamashita H et al. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat. Metab. Clin. Exp. 2002 Apr;51(4):403-8
Yamashita H et al
2002/01/01
PubMed
68 Ushida T et al. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model. Free Radic. Biol. Med. 2016 12;101:524-533
Ushida T et al
2016/01/01
PubMed
69 Wang W et al. Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. Free Radic. Biol. Med. 2015 Jun;83:214-26
Wang W et al
2015/01/01
PubMed
70 Queisser N et al. Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo. Free Radic. Biol. Med. 2013 Jan;54:17-25
Queisser N et al
2013/01/01
PubMed
71 Nilsson UA et al. The fungal nephrotoxin orellanine simultaneously increases oxidative stress and down-regulates cellular defenses. Free Radic. Biol. Med. 2008 Apr;44(8):1562-9
Nilsson UA et al
2008/01/01
PubMed
72 Menne J et al. Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers. FASEB J. 2006 May;20(7):994-6
Menne J et al
2006/01/01
PubMed
73 Komers R et al. Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes. Br. J. Pharmacol. 2016 09;173(17):2573-88
Komers R et al
2016/01/01
PubMed
74 Shimizu S et al. Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney. Br. J. Pharmacol. 2011 May;163(2):272-82
Shimizu S et al
2011/01/01
PubMed
75 Sena CM et al. Metformin restores endothelial function in aorta of diabetic rats. Br. J. Pharmacol. 2011 May;163(2):424-37
Sena CM et al
2011/01/01
PubMed
76 Kuno Y et al. Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats. Br. J. Pharmacol. 2011 Mar;162(6):1389-400
Kuno Y et al
2011/01/01
PubMed
77 Sena CM et al. Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br. J. Pharmacol. 2008 Mar;153(5):894-906
Sena CM et al
2008/01/01
PubMed
78 Shibata T et al. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br. J. Pharmacol. 2000 Jun;130(3):495-504
Shibata T et al
2000/01/01
PubMed
79 Hueper K et al. Magnetic resonance diffusion tensor imaging for evaluation of histopathological changes in a rat model of diabetic nephropathy. Invest Radiol 2012 Jul;47(7):430-7
Hueper K et al
2012/01/01
PubMed
80 Wang B et al. Berberine Improved Aldo-Induced Podocyte Injury via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress Pathways both In Vivo and In Vitro. Cell. Physiol. Biochem. 2016;39(1):217-28
Wang B et al
2016/01/01
PubMed
81 Yang M et al. Connexin 43 is involved in aldosterone-induced podocyte injury. Cell. Physiol. Biochem. 2014;34(5):1652-62
Yang M et al
2014/01/01
PubMed
82 Hye Khan MA et al. Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy. Clin. Sci. 2016 Apr;130(8):587-99
Hye Khan MA et al
2016/01/01
PubMed
83 Olearczyk JJ et al. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clin. Sci. 2009 Jan;116(1):61-70
Olearczyk JJ et al
2009/01/01
PubMed
84 Dey A et al. Rofecoxib decreases renal injury in obese Zucker rats. Clin. Sci. 2004 Dec;107(6):561-70
Dey A et al
2004/01/01
PubMed
85 Komers R et al. Renal p38 MAP kinase activity in experimental diabetes. Lab. Invest. 2007 Jun;87(6):548-58
Komers R et al
2007/01/01
PubMed
86 Mima A et al. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Lab. Invest. 2006 Sep;86(9):927-39
Mima A et al
2006/01/01
PubMed
87 Matsubara T et al. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Invest. 2006 Apr;86(4):357-68
Matsubara T et al
2006/01/01
PubMed
88 Dias LD et al. Renal denervation in an animal model of diabetes and hypertension: impact on the autonomic nervous system and nephropathy. Cardiovasc Diabetol 2011 Apr;10:33
Dias LD et al
2011/01/01
PubMed
89 Kim EY et al. Trpc6 inactivation confers protection in a model of severe nephrosis in rats. J. Mol. Med. 2018 07;96(7):631-644
Kim EY et al
2018/01/01
PubMed
90 Benipal B et al. Influence of renal compensatory hypertrophy on mitochondrial energetics and redox status. Biochem. Pharmacol. 2011 Jan;81(2):295-303
Benipal B et al
2011/01/01
PubMed
91 Shevalye H et al. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model. Biochem. Pharmacol. 2010 Apr;79(7):1007-14
Shevalye H et al
2010/01/01
PubMed
92 Nakagawa S et al. mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats. Biochem. Pharmacol. 2010 Jan;79(1):67-76
Nakagawa S et al
2010/01/01
PubMed
93 Yokoo S et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem. Pharmacol. 2007 Aug;74(3):477-87
Yokoo S et al
2007/01/01
PubMed
94 Zhao X et al. Albumin induces CD44 expression in glomerular parietal epithelial cells by activating extracellular signal-regulated kinase 1/2 pathway. J. Cell. Physiol. 2019 05;234(5):7224-7235
Zhao X et al
2019/01/01
PubMed
95 Peixoto EB et al. Reduced LRP6 expression and increase in the interaction of GSK3β with p53 contribute to podocyte apoptosis in diabetes mellitus and are prevented by green tea. J. Nutr. Biochem. 2015 Apr;26(4):416-30
Peixoto EB et al
2015/01/01
PubMed
96 Papadimitriou A et al. Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFβ-1 signaling. J. Nutr. Biochem. 2014 Jul;25(7):773-84
Papadimitriou A et al
2014/01/01
PubMed
97 Tost探es RM et al. Perfusion of 3D encapsulated hepatocytes--a synergistic effect enhancing long-term functionality in bioreactors. Biotechnol. Bioeng. 2011 Jan;108(1):41-9
Tost探es RM et al
2011/01/01
PubMed
98 Sena CM et al. Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol. Res. 2012 May;65(5):497-506
Sena CM et al
2012/01/01
PubMed
99 Paeng J et al. The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions. Nephrol. Dial. Transplant. 2017 01;32(1):61-72
Paeng J et al
2017/01/01
PubMed
100 Lee EY et al. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes. Nephrol. Dial. Transplant. 2012 Nov;27(11):4069-79
Lee EY et al
2012/01/01
PubMed
101 Jung DS et al. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease. Nephrol. Dial. Transplant. 2012 Jan;27(1):259-66
Jung DS et al
2012/01/01
PubMed
102 Furuichi K et al. Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrol. Dial. Transplant. 2011 Oct;26(10):3124-31
Furuichi K et al
2011/01/01
PubMed
103 Nagasu H et al. Renal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats. Nephrol. Dial. Transplant. 2010 Sep;25(9):2889-98
Nagasu H et al
2010/01/01
PubMed
104 Lee SH et al. Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy. Nephrol. Dial. Transplant. 2010 Jul;25(7):2134-41
Lee SH et al
2010/01/01
PubMed
105 Fujii H et al. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol. Dial. Transplant. 2009 Jul;24(7):2089-95
Fujii H et al
2009/01/01
PubMed
106 Xu ZG et al. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Nephrol. Dial. Transplant. 2009 Jun;24(6):1744-52
Xu ZG et al
2009/01/01
PubMed
107 Shibata R et al. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Nephrol. Dial. Transplant. 2009 Apr;24(4):1162-9
Shibata R et al
2009/01/01
PubMed
108 Satoh M et al. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol. Dial. Transplant. 2008 Dec;23(12):3806-13
Satoh M et al
2008/01/01
PubMed
109 Nakamura S et al. Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrol. Dial. Transplant. 2007 Aug;22(8):2165-74
Nakamura S et al
2007/01/01
PubMed
110 Boor P et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol. Dial. Transplant. 2007 May;22(5):1323-31
Boor P et al
2007/01/01
PubMed
111 Datta PK et al. Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis. Nephrol. Dial. Transplant. 2006 Jan;21(1):51-7
Datta PK et al
2006/01/01
PubMed
112 Suzuki H et al. Glomerular hyperfiltration and hypertrophy in the rat hypoplastic kidney as a model of oligomeganephronic disease. Nephrol. Dial. Transplant. 2005 Jul;20(7):1362-9
Suzuki H et al
2005/01/01
PubMed
113 Xu ZG et al. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. Nephrol. Dial. Transplant. 2005 Mar;20(3):524-31
Xu ZG et al
2005/01/01
PubMed
114 Drel VR et al. Poly(Adenosine 5-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. Endocrinology 2009 Dec;150(12):5273-83
Drel VR et al
2009/01/01
PubMed
115 Siragy HM et al. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats. Endocrinology 2003 Jun;144(6):2229-33
Siragy HM et al
2003/01/01
PubMed
116 Lane PH. 5-thio-D-glucose elevates renal transforming growth factor beta-1 at a dose that does not prevent streptozocine diabetes in rats. Endocrinology 2000 Sep;141(9):3337-42
Lane PH
2000/01/01
PubMed
117 Um JE et al. Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions. Sci Rep 2017 08;7(1):8490
Um JE et al
2017/01/01
PubMed
118 de Oliveira AA et al. Sustained kidney biochemical derangement in treated experimental diabetes: a clue to metabolic memory. Sci Rep 2017 01;7:40544
de Oliveira AA et al
2017/01/01
PubMed
119 Al-Ani B et al. Changes in urinary metabolomic profile during relapsing renal vasculitis. Sci Rep 2016 12;6:38074
Al-Ani B et al
2016/01/01
PubMed
120 Ueno Y et al. Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J. Nutr. 2002 May;132(5):897-900
Ueno Y et al
2002/01/01
PubMed
121 Guo QY et al. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2011 Apr;300(4):E708-16
Guo QY et al
2011/01/01
PubMed
122 Anderson RL et al. Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat. Am. J. Physiol. Endocrinol. Metab. 2010 Dec;299(6):E959-67
Anderson RL et al
2010/01/01
PubMed
123 Reinwald S et al. Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models. Am. J. Physiol. Endocrinol. Metab. 2009 Apr;296(4):E765-74
Reinwald S et al
2009/01/01
PubMed
124 Chen S et al. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am. J. Physiol. Endocrinol. Metab. 2003 Jun;284(6):E1089-97
Chen S et al
2003/01/01
PubMed
125 Brands MW et al. Decreased cardiac output at the onset of diabetes: renal mechanisms and peripheral vasoconstriction. Am. J. Physiol. Endocrinol. Metab. 2000 May;278(5):E917-24
Brands MW et al
2000/01/01
PubMed
126 Goto S et al. 22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes. Bone 2015 May;74:153-9
Goto S et al
2015/01/01
PubMed
127 Fujii H et al. Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. Bone 2008 Feb;42(2):372-9
Fujii H et al
2008/01/01
PubMed
128 Garg P et al. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. J. Biol. Chem. 2010 Jul;285(29):22676-88
Garg P et al
2010/01/01
PubMed
129 Nagai K et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 2003 May;278(20):18229-34
Nagai K et al
2003/01/01
PubMed
130 Kohzuki M et al. Renal-protective effect of non-depressor dose of cicletanine in streptozotocin diabetic rats. J. Hypertens. 1999 May;17(5):695-700
Kohzuki M et al
1999/01/01
PubMed
131 Detsika MG et al. Heme Oxygenase 1 Up-Regulates Glomerular Decay Accelerating Factor Expression and Minimizes Complement Deposition and Injury. Am. J. Pathol. 2016 11;186(11):2833-2845
Detsika MG et al
2016/01/01
PubMed
132 Ojima A et al. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression
Ojima A et al
2013/01/01
PubMed
133 Little MA et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am. J. Pathol. 2009 Apr;174(4):1212-20
Little MA et al
2009/01/01
PubMed
134 Socha MJ et al. Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am. J. Pathol. 2007 Oct;171(4):1104-12
Socha MJ et al
2007/01/01
PubMed
135 Makibayashi K et al. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am. J. Pathol. 2001 May;158(5):1733-41
Makibayashi K et al
2001/01/01
PubMed
136 Yanagita M et al. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am. J. Pathol. 2001 Apr;158(4):1423-32
Yanagita M et al
2001/01/01
PubMed
137 Nomura A et al. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am. J. Pathol. 1997 Aug;151(2):539-47
Nomura A et al
1997/01/01
PubMed
138 Ebenezer PJ et al. Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) 2009 Nov;17(11):1994-2002
Ebenezer PJ et al
2009/01/01
PubMed
139 Akahori H et al. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression. J. Pharmacol. Exp. Ther. 2005 Aug;314(2):514-21
Akahori H et al
2005/01/01
PubMed
140 Aleo MD et al. Model development and analysis of tenidap-induced proteinuria in the rat. J. Pharmacol. Exp. Ther. 1996 Dec;279(3):1318-26
Aleo MD et al
1996/01/01
PubMed
141 Lee SH et al. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions. Apoptosis 2015 Aug;20(8):1056-71
Lee SH et al
2015/01/01
PubMed
142 Paeng J et al. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions. Apoptosis 2014 Dec;19(12):1678-90
Paeng J et al
2014/01/01
PubMed
143 Kwak SJ et al. Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions. Apoptosis 2011 May;16(5):478-90
Kwak SJ et al
2011/01/01
PubMed
144 Nussler AK et al. The suitability of hepatocyte culture models to study various aspects of drug metabolism. ALTEX 2001;18(2):91-101
Nussler AK et al
2001/01/01
PubMed
145 Poon R et al. Short-term oral toxicity of three biodiesels and an ultra-low sulfur diesel in male rats. Food Chem. Toxicol. 2009 Jul;47(7):1416-24
Poon R et al
2009/01/01
PubMed
146 Poon R et al. Effects of three biodiesels and a low sulfur diesel in male rats--a pilot 4-week oral study. Food Chem. Toxicol. 2007 Oct;45(10):1830-7
Poon R et al
2007/01/01
PubMed
147 Koch M et al. Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients. Transplantation 2007 Feb;83(4):498-505
Koch M et al
2007/01/01
PubMed
148 Koch M et al. Adoptive transfer of primed CD4+ T-lymphocytes induces pattern of chronic allograft nephropathy in a nude rat model. Transplantation 2005 Apr;79(7):753-61
Koch M et al
2005/01/01
PubMed
149 Yamashita T et al. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats. Diabetes Res. Clin. Pract. 2002 Sep;57(3):149-61
Yamashita T et al
2002/01/01
PubMed
150 Whitney JL et al. Growth hormone exacerbates diabetic renal damage in male but not female rats. Biol Sex Differ 2013;4:12
Whitney JL et al
2013/01/01
PubMed
151 Meli DN et al. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect. Immun. 2006 Jul;74(7):3890-6
Meli DN et al
2006/01/01
PubMed
152 Ishikawa N et al. Genetic effects of blood pressure quantitative trait loci on hypertension-related organ damage: evaluation using multiple congenic strains. Hypertens. Res. 2008 Sep;31(9):1773-9
Ishikawa N et al
2008/01/01
PubMed
153 Fujii S et al. Albuminuria, expression of nicotinamide adenine dinucleotide phosphate oxidase and monocyte chemoattractant protein-1 in the renal tubules of hypertensive Dahl salt-sensitive rats. Hypertens. Res. 2007 Oct;30(10):991-8
Fujii S et al
2007/01/01
PubMed
154 Kanazawa M et al. Renoprotective effect of angiotensin-converting enzyme inhibitor combined with alpha1-adrenergic antagonist in spontaneously hypertensive rats with renal ablation. Hypertens. Res. 2004 Jul;27(7):509-15
Kanazawa M et al
2004/01/01
PubMed
155 Hagiwara M et al. Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats. Hypertens. Res. 2004 Jun;27(6):399-408
Hagiwara M et al
2004/01/01
PubMed
156 Kanazawa M et al. Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation. Hypertens. Res. 200
Kanazawa M et al
2002/01/01
PubMed
157 Khan AH et al. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome. Am. J. Hypertens. 2011 Jul;24(7):816-21
Khan AH et al
2011/01/01
PubMed
158 Kohzuki M et al. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension. Am. J. Hypertens. 2000 Mar;13(3):298-306
Kohzuki M et al
2000/01/01
PubMed
159 Kitada M et al. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res 2011;2011:9
Kitada M et al
2011/01/01
PubMed
160 Xu XX et al. Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats. Phytomedicine 2014 May;21(6):815-23
Xu XX et al
2014/01/01
PubMed
161 Xu XX et al. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats. Phytomedicine 2013 Jul;20(10):820-7
Xu XX et al
2013/01/01
PubMed
162 Su J et al. Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats. Phytomedicine 2010 Mar;17(3-4):254-60
Su J et al
2010/01/01
PubMed
163 Wu Y et al. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 2008 Oct;44(1):85-91
Wu Y et al
2008/01/01
PubMed
164 Shimizu Y et al. Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2005 Apr;288(4):G664-70
Shimizu Y et al
2005/01/01
PubMed
165 Ovcharenko E et al. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat. Nephron Physiol 2010;115(3):p21-30
Ovcharenko E et al
2010/01/01
PubMed
166 Konda T et al. The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome. Nephron Physiol 2005;101(1):p1-13
Konda T et al
2005/01/01
PubMed
167 Schaan BD et al. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes. Nephron Physiol 2005;100(3):p43-50
Schaan BD et al
2005/01/01
PubMed
168 Sugimachi M et al. Endogenous endothelin in a rat model of acute colonic mucosal injury. J. Gastroenterol. Hepatol. 2000 Oct;15(10):1125-31
Sugimachi M et al
2000/01/01
PubMed
169 Aritomi S et al. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet. Heart Vessels 2010 Nov;25(6):549-55
Aritomi S et al
2010/01/01
PubMed
170 Cohen MP et al. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation. Invest. Ophthalmol. Vis. Sci. 2008 Nov;49(11):5089-93
Cohen MP et al
2008/01/01
PubMed
171 Gu JW et al. Long-term High Salt Diet Causes Hypertension and Decreases Renal Expression of Vascular Endothelial Growth Factor in Sprague-Dawley Rats. J Am Soc Hypertens ;2(4):275-85
Gu JW et al
PubMed
172 Ecelbarger CM et al. The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat. Mediators Inflamm. 2010;2010:841343
Ecelbarger CM et al
2010/01/01
PubMed
173 Chen X et al. Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells. Int J Mol Sci 2017 Aug;18(8)
Chen X et al
2017/01/01
PubMed
174 Xu HZ et al. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance. Int J Mol Sci 2016 May;17(5)
Xu HZ et al
2016/01/01
PubMed
175 Wang K et al. Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys. Am. J. Chin. Med. 2012;40(3):521-36
Wang K et al
2012/01/01
PubMed
176 Zhang P et al. Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats. Am. J. Chin. Med. 2009;37(2):295-307
Zhang P et al
2009/01/01
PubMed
177 Wang MX et al. Nuciferine Alleviates Renal Injury by Inhibiting Inflammatory Responses in Fructose-Fed Rats. J. Agric. Food Chem. 2016 Oct;64(42):7899-7910
Wang MX et al
2016/01/01
PubMed
178 Said E et al. Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats. Chem. Biol. Interact. 2018 Feb;281:111-120
Said E et al
2018/01/01
PubMed
179 Hamzawy M et al. The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy. Endocrine 2017 Oct;58(1):66-80
Hamzawy M et al
2017/01/01
PubMed
180 Wang X et al. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther. 2006 Jul;13(14):1097-103
Wang X et al
2006/01/01
PubMed
181 Watanabe S et al. Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease. Kidney Blood Press. Res. 2018;43(6):1716-1729
Watanabe S et al
2018/01/01
PubMed
182 Hu Z et al. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats. Kidney Blood Press. Res. 2012;36(1):85-97
Hu Z et al
2012/01/01
PubMed
183 Lecian D et al. Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis. Kidney Blood Press. Res. 2006;29(3):135-43
Lecian D et al
2006/01/01
PubMed
184 Sui Y et al. A branched arabinoglucan from Angelica sinensis ameliorates diabetic renal damage in rats. Phytother Res 2019 Mar;33(3):818-831
Sui Y et al
2019/01/01
PubMed
185 Doege C et al. Chronic allograft nephropathy in athymic nude rats after adoptive transfer of primed T lymphocytes. Transpl. Int. 2005 Aug;18(8):981-91
Doege C et al
2005/01/01
PubMed
186 Paauw ND et al. Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2017 05;312(5):R664-R670
Paauw ND et al
2017/01/01
PubMed
187 Gu JW et al. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Jul;297(1):R142-8
Gu JW et al
2009/01/01
PubMed
188 Abdel-Rahman EM et al. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008 Nov;295(5):R1473-8
Abdel-Rahman EM et al
2008/01/01
PubMed
189 Mankhey RW et al. 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 Feb;292(2):R769-77
Mankhey RW et al
2007/01/01
PubMed
190 Gu JW et al. Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 Dec;291(6):R1817-24
Gu JW et al
2006/01/01
PubMed
191 Fitzgerald SM et al. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001 Aug;281(2):R547-52
Fitzgerald SM et al
2001/01/01
PubMed
192 Zhang M et al. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol 2012 May;141(1):111-8
Zhang M et al
2012/01/01
PubMed
193 Liu IM et al. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. J Ethnopharmacol 2009 Jul;124(2):211-8
Liu IM et al
2009/01/01
PubMed
194 Kitada M et al. A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity. Nutr Metab (Lond) 2018;15:20
Kitada M et al
2018/01/01
PubMed
195 Tzeng TF et al. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutr Metab (Lond) 2013 Oct;10(1):64
Tzeng TF et al
2013/01/01
PubMed
196 Mozaffari MS et al. Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab (Lond) 2009 Dec;6:51
Mozaffari MS et al
2009/01/01
PubMed
197 Qi XM et al. FK506 ameliorates renal injury in early experimental diabetic rats induced by streptozotocin. Int. Immunopharmacol. 2011 Oct;11(10):1613-9
Qi XM et al
2011/01/01
PubMed
198 Wu YG et al. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes. Int. Immunopharmacol. 2006 Mar;6(3):445-53
Wu YG et al
2006/01/01
PubMed
199 Jesmin S et al. Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis. Inflammation 2012 Apr;35(2):484-500
Jesmin S et al
2012/01/01
PubMed
200 da Silva AS et al. Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats. Life Sci. 2013 Jul;92(24-26):1174-9
da Silva AS et al
2013/01/01
PubMed
201 Ebenezer PJ et al. Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats. Life Sci. 2009 Aug;85(9-10):357-64
Ebenezer PJ et al
2009/01/01
PubMed
202 Siragy HM et al. Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats. Exp. Physiol. 2008 Jul;93(7):817-24
Siragy HM et al
2008/01/01
PubMed
203 Castoldi G et al. Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect. Biosci. Rep. 2016 Dec;36(6)
Castoldi G et al
2016/01/01
PubMed
204 H旦llriegl W et al. Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis. Eur. J. Pharmacol. 2018 Feb;820:206-216
H旦llriegl W et al
2018/01/01
PubMed
205 Kang ES et al. Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur. J. Pharmacol. 2008 Jan;579(1-3):418-25
Kang ES et al
2008/01/01
PubMed
206 Saito M et al. N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy. Eur. J. Pharmacol. 2006 Aug;544(1-3):132-7
Saito M et al
2006/01/01
PubMed
207 Granitzny A et al. Maintenance of high quality rat precision cut liver slices during culture to study hepatotoxic responses: Acetaminophen as a model compound. Toxicol In Vitro 2017 Aug;42:200-213
Granitzny A et al
2017/01/01
PubMed
208 Leite SB et al. Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: Improved in vitro models for toxicological applications. Toxicol In Vitro 2011 Jun;25(4):825-32
Leite SB et al
2011/01/01
PubMed
209 Niu HS et al. Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats. Drug Des Devel Ther 2016;10:971-8
Niu HS et al
2016/01/01
PubMed
210 Mori Y et al. Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus. Drug Des Devel Ther 2014;8:
Mori Y et al
2014/01/01
PubMed
211 Fujii H et al. The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus. Cardiovasc Drugs Ther 2015 Dec;29(6):499-507
Fujii H et al
2015/01/01
PubMed
212 Zhao T et al. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats. PLoS ONE 2016;11(1):e0147693
Zhao T et al
2016/01/01
PubMed
213 Mansuri A et al. Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion. PLoS ONE 2015;10(12):e0146183
Mansuri A et al
2015/01/01
PubMed
214 Berger RC et al. Renal Effects and Underlying Molecular Mechanisms of Long-Term Salt Content Diets in Spontaneously Hypertensive Rats. PLoS ONE 2015;10(10):e0141288
Berger RC et al
2015/01/01
PubMed
215 Kelly KJ et al. Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy. PLoS ONE 2015;10(7):e0131677
Kelly KJ et al
2015/01/01
PubMed
216 Nair AR et al. A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway. PLoS ONE 2014;9(11):e111976
Nair AR et al
2014/01/01
PubMed
217 Gomes CL et al. The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy. PLoS ONE 2014;9(9):e106929
Gomes CL et al
2014/01/01
PubMed
218 Di Marco GS et al. Circulating endothelial progenitor cells in kidney transplant patients. PLoS ONE 2011;6(9):e24046
Di Marco GS et al
2011/01/01
PubMed
219 Yokoyama M et al. Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Nutr Res 2010 Mar;30(3):217-25
Yokoyama M et al
2010/01/01
PubMed
220 Flynn ER et al. C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat. J. Diabetes Complicat. ;27(6):538-47
Flynn ER et al
PubMed
221 Chen X et al. Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model. J Diabetes Res 2018;2018:8968573
Chen X et al
2018/01/01
PubMed
222 He Y et al. Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model. J Diabetes Res 2016;2016:4157313
He Y et al
2016/01/01
PubMed
223 Sayed AA. Ferulsinaic acid attenuation of diabetic nephropathy. Eur. J. Clin. Invest. 2013 Jan;43(1):56-63
Sayed AA
2013/01/01
PubMed
224 Xin HG et al. Consumption of hydrogen-rich water alleviates renal injury in spontaneous hypertensive rats. Mol. Cell. Biochem. 2014 Jul;392(1-2):117-24
Xin HG et al
2014/01/01
PubMed
225 Okada S et al. Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy. Mol. Cell. Biochem. 2008 Aug;315(1-2):169-77
Okada S et al
2008/01/01
PubMed
226 Qi XM et al. FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats. Inflamm. Res. 2016 Feb;65(2):103-14
Qi XM et al
2016/01/01
PubMed
227 Wu YG et al. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats. Inflamm. Res. 2006 May;55(5):192-9
Wu YG et al
2006/01/01
PubMed
228 Castoldi G et al. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Am. J. Nephrol. 2013;37(1):65-73
Castoldi G et al
2013/01/01
PubMed
229 Goto S et al. Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes. Am. J. Nephrol. 2011;34(3):281-90
Goto S et al
2011/01/01
PubMed
230 Setti G et al. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes. Am. J. Nephrol. 2010;32(5):393-402
Setti G et al
2010/01/01
PubMed
231 Fujii H et al. Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes. Am. J. Nephrol. 2010;31(4):342-52
Fujii H et al
2010/01/01
PubMed
232 Whaley-Connell A et al. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury. Am. J. Nephrol. 2008;28(1):67-75
Whaley-Connell A et al
2008/01/01
PubMed
233 Satoh M et al. In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats. Microcirculation 2010 Feb;17(2):103-12
Satoh M et al
2010/01/01
PubMed
234 Laflam PF et al. Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats. Pediatr. Nephrol. 2006 Feb;21(2):177-81
Laflam PF et al
2006/01/01
PubMed
235 Garin EH et al. Anti-interleukin 8 antibody abolishes effects of lipoid nephrosis cytokine. Pediatr. Nephrol. 1998 Jun;12(5):381-5
Garin EH et al
1998/01/01
PubMed
236 Garin EH et al. Effect of interleukin-8 on glomerular sulfated compounds and albuminuria. Pediatr. Nephrol. 1997 Jun;11(3):274-9
Garin EH et al
1997/01/01
PubMed
237 Garin EH. Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria. Pediatr. Nephrol. 1995 Oct;9(5):587-93
Garin EH
1995/01/01
PubMed
238 Koh JH et al. Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model. Int J Endocrinol 2014;2014:397307
Koh JH et al
2014/01/01
PubMed
239 Cutler JL et al. Effects of ototopical antihistamine on otitis media in an allergic rat. Laryngoscope 2008 Feb;118(2):283-7
Cutler JL et al
2008/01/01
PubMed
240 Tsuda Y et al. Heterotypic cell interactions on a dually patterned surface. Biochem. Biophys. Res. Commun. 2006 Sep;348(3):937-44
Tsuda Y et al
2006/01/01
PubMed
241 Huang H et al. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats. J. Sci. Food Agric. 2017 Mar;97(4):1359-1366
Huang H et al
2017/01/01
PubMed
242 Siddique K et al. Effect of Postnatal Maternal Protein Intake on Prenatal Programming of Hypertension. Reprod Sci 2014 Apr;
Siddique K et al
2014/01/01
PubMed
243 Zhang W et al. Total glucosides of paeony attenuate renal tubulointerstitial injury in STZ-induced diabetic rats: role of Toll-like receptor 2. J. Pharmacol. Sci. 2014;125(1):59-67
Zhang W et al
2014/01/01
PubMed
244 Wu Y et al. Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes. J. Pharmacol. Sci. 2009 Jan;109(1):78-87
Wu Y et al
2009/01/01
PubMed
245 Atsaves V et al. Phenotypic characterization of a novel HO-1 depletion model in the rat. Transgenic Res. 2017 02;26(1):51-64
Atsaves V et al
2017/01/01
PubMed
246 Hu X et al. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways. Fundam Clin Pharmacol 2017 Feb;31(1):54-63
Hu X et al
2017/01/01
PubMed
247 Oh SW et al. Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis. BMC Nephrol 2013 May;14:105
Oh SW et al
2013/01/01
PubMed
248 Lu HJ et al. Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways. BMC Complement Altern Med 2014 May;14:156
Lu HJ et al
2014/01/01
PubMed
249 Lu HJ et al. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. BMC Complement Altern Med 2014 Mar;14:110
Lu HJ et al
2014/01/01
PubMed
250 Cutler JL et al. Effects of ototopic steroid and NSAIDS in clearing middle ear effusion in an animal model. Otolaryngol Head Neck Surg 2006 Oct;135(4):585-9
Cutler JL et al
2006/01/01
PubMed
251 Sugimoto K et al. Renal protective effect of YM598, a selective endothelin type A receptor antagonist. J. Cardiovasc. Pharmacol. 2004 Nov;44 Suppl 1:S451-4
Sugimoto K et al
2004/01/01
PubMed
252 Mozaffari MS et al. Renoprotective effects of chronic candesartan treatment in uninephrectomized rat. J. Cardiovasc. Pharmacol. 2003 Jan;41(1):81-8
Mozaffari MS et al
2003/01/01
PubMed
253 Wu Y et al. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. Nephron Exp. Nephrol. 2014;128(1-2):46-56
Wu Y et al
2014/01/01
PubMed
254 Ishiguro K et al. Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy. Nephron Exp. Nephrol. 2008;109(1):e20-8
Ishiguro K et al
2008/01/01
PubMed
255 Qi XM et al. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats. Nephron Exp. Nephrol. 2006;104(4):e147-57
Qi XM et al
2006/01/01
PubMed
256 Garin EH et al. Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome. Nephron Exp. Nephrol. 2006;102(3-4):e105-12
Garin EH et al
2006/01/01
PubMed
257 Furuse Y et al. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats. Nephron Exp. Nephrol. 2004;98(3):e100-8
Furuse Y et al
2004/01/01
PubMed
258 Xu HZ et al. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli. J. Nephrol. 2016 Dec;29(6):775-782
Xu HZ et al
2016/01/01
PubMed
259 Ogura Y et al. Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats. Redox Rep. 2018 Dec;23(1):153-159
Ogura Y et al
2018/01/01
PubMed
260 Ma Y et al. The renoprotective effect of shichimotsukokato on hypertension-induced renal dysfunction in spontaneously hypertensive rats. J Nat Med 2016 Apr;70(2):152-62
Ma Y et al
2016/01/01
PubMed
261 Zhou L et al. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food 2012 May;15(5):461-8
Zhou L et al
2012/01/01
PubMed
262 Atsaves V et al. Glomerular Epithelial Cells-Targeted Heme Oxygenase-1 Over Expression in the Rat: Attenuation of Proteinuria in Secondary But Not Primary Injury. Nephron 2016;133(4):270-8
Atsaves V et al
2016/01/01
PubMed
263 Chen S et al. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 2002 Jan;90(1):86-94
Chen S et al
2002/01/01
PubMed
264 Nakashima A et al. Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis. Nephron 1996;73(1):34-40
Nakashima A et al
1996/01/01
PubMed
265 Donnelly SM et al. Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat. Biochem. Cell Biol. 1996;74(3):355-62
Donnelly SM et al
1996/01/01
PubMed
266 Reisin E et al. Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet. Am. J. Med. Sci. 2009 Oct;338(4):301-9
Reisin E et al
2009/01/01
PubMed
267 Liu IM et al. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats. J. Food Sci. 2011 Sep;76(7):H165-74
Liu IM et al
2011/01/01
PubMed
268 Koch M et al. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection. Transpl. Immunol. 2016 Mar;35:12-7
Koch M et al
2016/01/01
PubMed
269 Lemke A et al. Rat renal transplant model for mixed acute humoral and cellular rejection: Weak correlation of serum cytokines/chemokines with intragraft changes. Transpl. Immunol. 2015 Oct;33(2):95-102
Lemke A et al
2015/01/01
PubMed
270 Koch M et al. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transpl. Immunol. 2013 Dec;29(1-4):43-50
Koch M et al
2013/01/01
PubMed
271 Poehnert D et al. Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility. Transpl. Immunol. 2010 Feb;22(3-4):137-43
Poehnert D et al
2010/01/01
PubMed
272 Koch M et al. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model. Transpl. Immunol. 2008 Jul;19(3-4):187-91
Koch M et al
2008/01/01
PubMed
273 Hamzawy M et al. 22-oxacalcitriol prevents acute kidney injury via inhibition of apoptosis and enhancement of autophagy. Clin. Exp. Nephrol. 2019 Jan;23(1):43-55
Hamzawy M et al
2019/01/01
PubMed
274 Yamada-Obara N et al. Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clin. Exp. Nephrol. 2016 Dec;20(6):853-861
Yamada-Obara N et al
2016/01/01
PubMed
275 Kobayashi S et al. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy. Clin. Exp. Nephrol. 2008 Apr;12(2):119-125
Kobayashi S et al
2008/01/01
PubMed
276 Qusti S et al. The Hypoglycemic and Antioxidant Activity of Cress Seed and Cinnamon on Streptozotocin Induced Diabetes in Male Rats. Evid Based Complement Alternat Med 2016;2016:5614564
Qusti S et al
2016/01/01
PubMed
277 Al-Malki AL. Oat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B. Evid Based Complement Alternat Med 2013;2013:609745
Al-Malki AL
2013/01/01
PubMed
278 Lu HJ et al. An Aqueous-Ethanol Extract of Liriope spicata var. prolifera Ameliorates Diabetic Nephropathy through Suppression of Renal Inflammation. Evid Based Complement Alternat Med 2013;2013:201643
Lu HJ et al
2013/01/01
PubMed
279 Al-Malki AL et al. Proanthocyanidin Attenuation of Oxidative Stress and NF- κ B Protects Apolipoprotein E-Deficient Mice against Diabetic Nephropathy. Evid Based Complement Alternat Med 2013;2013:769409
Al-Malki AL et al
2013/01/01
PubMed
280 Tzeng TF et al. The Ethanol Extract of Zingiber zerumbet Attenuates Streptozotocin-Induced Diabetic Nephropathy in Rats. Evid Based Complement Alternat Med 2013;2013:340645
Tzeng TF et al
2013/01/01
PubMed
281 Sayed AA. Ferulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic Kidney. Evid Based Complement Alternat Med 2012;2012:580104
Sayed AA
2012/01/01
PubMed
282 Liu IM et al. Beneficial effect of traditional chinese medicinal formula danggui-shaoyao-san on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats. Evid Based Complement Alternat Med 2012;2012:140103
Liu IM et al
2012/01/01
PubMed
283 Li X et al. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model. Mol Med Rep 2017 Dec;16(6):9393-9400
Li X et al
2017/01/01
PubMed
284 Shi H et al. Effects of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro. Mol Med Rep 2016 Jun;13(6):5102-8
Shi H et al
2016/01/01
PubMed
285 Namikoshi T et al. High dietary protein intake induces endothelial dysfunction in uninephrectomized rats. Mol Med Rep ;2(3):429-34
Namikoshi T et al
PubMed
286 Shimizu K et al. Increased oxidized protein hydrolase activity in serum and urine of diabetic rat models. Biol. Pharm. Bull. 2009 Sep;32(9):1632-5
Shimizu K et al
2009/01/01
PubMed
287 Souza MS et al. Reduced cortical renal GLUT1 expression induced by angiotensin-converting enzyme inhibition in diabetic spontaneously hypertensive rats. Braz. J. Med. Biol. Res. 2008 Nov;41(11):960-8
Souza MS et al
2008/01/01
PubMed
288 Kitada M et al. Cyclic and intermittent very low-protein diet can have beneficial effects against advanced diabetic nephropathy in Wistar fatty (fa/fa) rats, an animal model of type 2 diabetes and obesity. Nephrology (Carlton) 2017 Dec;22(12):1030-1034
Kitada M et al
2017/01/01
PubMed
289 Yanes LL et al. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med 2011 Apr;8(2):103-15
Yanes LL et al
2011/01/01
PubMed
290 Ji H et al. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med 2007 Mar;4(1):56-71
Ji H et al
2007/01/01
PubMed
291 Kim BH et al. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy. Yonsei Med. J. 2016 May;57(3):664-73
Kim BH et al
2016/01/01
PubMed
292 Kim DH et al. Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy. Yonsei Med. J. 2012 Nov;53(6):1165-75
Kim DH et al
2012/01/01
PubMed
293 Neuman RG et al. Glycated albumin: a marker of glycaemic status in rats with experimental diabetes. Lab. Anim. 1994 Jan;28(1):63-9
Neuman RG et al
1994/01/01
PubMed
294 Yang J et al. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway. Immunopharmacol Immunotoxicol 2016;38(2):145-52
Yang J et al
2016/01/01
PubMed
295 Follansbee MH et al. Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats. Pharmacology 1997 May;54(5):241-55
Follansbee MH et al
1997/01/01
PubMed
296 Beyer-Mears A et al. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus. Pharmacology 1996 May;52(5):292-302
Beyer-Mears A et al
1996/01/01
PubMed
297 Pess担a BS et al. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin Angiotensin Aldosterone Syst 2012 Mar;13(1):56-66
Pess担a BS et al
2012/01/01
PubMed
298 Katsuda Y et al. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. Exp. Anim. 2015;64(2):161-9
Katsuda Y et al
2015/01/01
PubMed
299 Kawakami T et al. Protective effect of composite earthworm powder against diabetic complications via increased fibrinolytic function and improvement of lipid metabolism in ZDF rats. Biosci. Biotechnol. Biochem. 2016 Oct;80(10):1980-9
Kawakami T et al
2016/01/01
PubMed
300 Nakagiri R et al. Small scale rat hepatocyte primary culture with applications for screening hepatoprotective substances. Biosci. Biotechnol. Biochem. 2003 Aug;67(8):1629-35
Nakagiri R et al
2003/01/01
PubMed
301 Nickels DA et al. Effect of chronic growth hormone administration on diabetic nephropathy in the rat. Ann. Clin. Lab. Sci. ;23(6):462-8
Nickels DA et al
PubMed
302 Tanaka T et al. Thiamine prevents obesity and obesity-associated metabolic disorders in OLETF rats. J. Nutr. Sci. Vitaminol. 2010;56(6):335-46
Tanaka T et al
2010/01/01
PubMed
303 Castoldi G et al. Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis. Clin. Exp. Pharmacol. Physiol. 2016 Mar;43(3):335-42
Castoldi G et al
2016/01/01
PubMed
304 Yonekura Y et al. Anti-oxidative effect of the β-blocker carvedilol on diabetic nephropathy in non-obese type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2015 Sep;42(9):972-978
Yonekura Y et al
2015/01/01
PubMed
305 Sun SF et al. Renoprotective effect of berberine on type 2 diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2015 Jun;42(6):662-70
Sun SF et al
2015/01/01
PubMed
306 Aritomi S et al. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2015 Apr;42(4):344-52
Aritomi S et al
2015/01/01
PubMed
307 Ling C et al. Ursolic Acid provides kidney protection in diabetic rats. Curr Ther Res Clin Exp 2013 Dec;75:59-63
Ling C et al
2013/01/01
PubMed
308 Miranda JP et al. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors. Tissue Eng Part C Methods 2010 Dec;16(6):1223-32
Miranda JP et al
2010/01/01
PubMed
309 Matavelli LC et al. (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation. Clin. Exp. Pharmacol. Physiol. 2010 Mar;37(3):277-82
Matavelli LC et al
2010/01/01
PubMed
310 Miranda JP et al. Towards an extended functional hepatocyte in vitro culture. Tissue Eng Part C Methods 2009 Jun;15(2):157-67
Miranda JP et al
2009/01/01
PubMed
311 Sonalker PA et al. Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-2. Clin. Exp. Pharmacol. Physiol. 2008 May;35(5-6):594-600
Sonalker PA et al
2008/01/01
PubMed
312 Komers R et al. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats. Clin. Exp. Pharmacol. Physiol. ;34(1-2):36-41
Komers R et al
PubMed
313 Itoh Y et al. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative. Horm. Res. 2001;56(5-6):165-71
Itoh Y et al
2001/01/01
PubMed
314 Kim EY et al. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions. Biochem Biophys Rep 2019 Mar;17:139-150
Kim EY et al
2019/01/01
PubMed
315 Torres Fernandez ED et al. Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome. J Endocr Soc 2018 Aug;2(8):949-964
Torres Fernandez ED et al
2018/01/01
PubMed
316 Cobbs A et al. Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells. Int J Physiol Pathophysiol Pharmacol 2018;10(1):29-38
Cobbs A et al
2018/01/01
PubMed
317 Kurosaki Y et al. Oxidative stress increases megalin expression in the renal proximal tubules during the normoalbuminuric stage of diabetes mellitus. Am. J. Physiol. Renal Physiol. 2018 03;314(3):F462-F470
Kurosaki Y et al
2018/01/01
PubMed
318 Mansuri A et al. Effect of renal denervation on urine angiotensinogen excretion in prenatally programmed rats. Physiol Rep 2017 Nov;5(20)
Mansuri A et al
2017/01/01
PubMed
319 Yeboah MM et al. The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats. Am. J. Physiol. Renal Physiol. 2016 09;311(3):F576-85
Yeboah MM et al
2016/01/01
PubMed
320 Casare FA et al. Renovascular remodeling and renal injury after extended angiotensin II infusion. Am. J. Physiol. Renal Physiol. 2016 06;310(11):F1295-307
Casare FA et al
2016/01/01
PubMed
321 Lozano G et al. Effect of prenatal programming and postnatal rearing on glomerular filtration rate in adult rats. Am. J. Physiol. Renal Physiol. 2015 Mar;308(5):F411-9
Lozano G et al
2015/01/01
PubMed
322 Mittwede PN et al. Oxidative stress contributes to orthopedic trauma-induced acute kidney injury in obese rats. Am. J. Physiol. Renal Physiol. 2015 Jan;308(2):F157-63
Mittwede PN et al
2015/01/01
PubMed
323 Papadimitriou A et al. Theobromine increases NAD⁺/Sirt-1 activity and protects the kidney under diabetic conditions. Am. J. Physiol. Renal Physiol. 2015 Feb;308(3):F209-25
Papadimitriou A et al
2015/01/01
PubMed
324 Arruda-Junior DF et al. Reduced tubular proteinuria in hypertensive rats treated with losartan is associated with higher renal cortical megalin expression. Horm Mol Biol Clin Investig 2014 May;18(2):105-12
Arruda-Junior DF et al
2014/01/01
PubMed
325 Castoldi G et al. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats. Am. J. Physiol. Renal Physiol. 2014 Nov;307(10):F1123-31
Castoldi G et al
2014/01/01
PubMed
326 Mittwede PN et al. A novel experimental model of orthopedic trauma with acute kidney injury in obese Zucker rats. Physiol Rep 2013 Oct;1(5):e00097
Mittwede PN et al
2013/01/01
PubMed
327 Kelly KJ et al. Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2013 Dec;305(12):F1804-12
Kelly KJ et al
2013/01/01
PubMed
328 Inoue BH et al. Progression of microalbuminuria in SHR is associated with lower expression of critical components of the apical endocytic machinery in the renal proximal tubule. Am. J. Physiol. Renal Physiol. 2013 Jul;305(2):F216-26
Inoue BH et al
2013/01/01
PubMed
329 Flynn ER et al. Amlodipine Reduces Inflammation despite Promoting Albuminuria in the Streptozotocin-Induced Diabetic Rat. Nephron Extra 2012 Jan;2(1):205-18
Flynn ER et al
2012/01/01
PubMed
330 Sawyer RT et al. Renoprotective effects of C-peptide in the Dahl salt-sensitive rat. Am. J. Physiol. Renal Physiol. 2012 Sep;303(6):F893-9
Sawyer RT et al
2012/01/01
PubMed
331 Tamura Y et al. Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. Am. J. Physiol. Renal Physiol. 2012 Aug;303(3):F339-49
Tamura Y et al
2012/01/01
PubMed
332 Anderson S et al. 2-Hydroxyestradiol slows progression of experimental polycystic kidney disease. Am. J. Physiol. Renal Physiol. 2012 Mar;302(5):F636-45
Anderson S et al
2012/01/01
PubMed
333 Ju KD et al. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2012 Mar;302(5):F606-13
Ju KD et al
2012/01/01
PubMed
334 Zoja C et al. Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. Am. J. Physiol. Renal Physiol. 2011 Nov;301(5):F1114-23
Zoja C et al
2011/01/01
PubMed
335 Zoja C et al. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Am. J. Physiol. Renal Physiol. 2010 Nov;299(5):F1203-11
Zoja C et al
2010/01/01
PubMed
336 Nishihara K et al. Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats. Am. J. Physiol. Renal Physiol. 2010 Apr;298(4):F923-34
Nishihara K et al
2010/01/01
PubMed
337 Lee SH et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am. J. Physiol. Renal Physiol. 2009 Nov;297(5):F1381-90
Lee SH et al
2009/01/01
PubMed
338 Gagliardini E et al. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am. J. Physiol. Renal Physiol. 2009 Nov;297(5):F1448-56
Gagliardini E et al
2009/01/01
PubMed
339 Xu Q et al. Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney. Am. J. Physiol. Renal Physiol. 2009 Aug;297(2):F307-15
Xu Q et al
2009/01/01
PubMed
340 Li JJ et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009 Jul;297(1):F200-9
Li JJ et al
2009/01/01
PubMed
341 Luo P et al. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009 Mar;296(3):F556-63
Luo P et al
2009/01/01
PubMed
342 Elks CM et al. Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F298-305
Elks CM et al
2009/01/01
PubMed
343 Garman JH et al. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F306-16
Garman JH et al
2009/01/01
PubMed
344 Jung DS et al. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F595-604
Jung DS et al
2008/01/01
PubMed
345 Dominguez JH et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am. J. Physiol. Renal Physiol. 2008 Jan;294(1):F110-9
Dominguez JH et al
2008/01/01
PubMed
346 Dixon A et al. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1678-90
Dixon A et al
2007/01/01
PubMed
347 Sun J et al. Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats. Am. J. Physiol. Renal Physiol. 2007 Jun;292(6):F1681-90
Sun J et al
2007/01/01
PubMed
348 Hayden MR et al. Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat. Am. J. Physiol. Renal Physiol. 2007 Feb;292(2):F861-7
Hayden MR et al
2007/01/01
PubMed
349 S叩nchez-Lozada LG et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal Physiol. 2007 Jan;292(1):F423-9
S叩nchez-Lozada LG et al
2007/01/01
PubMed
350 Whaley-Connell AT et al. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am. J. Physiol. Renal Physiol. 2006 Dec;291(6):F1308-14
Whaley-Connell AT et al
2006/01/01
PubMed
351 Karumanchi SA et al. In vivo rat model of preeclampsia. Methods Mol. Med. 2006;122:393-9
Karumanchi SA et al
2006/01/01
PubMed
352 Khan O et al. Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone. Am. J. Physiol. Renal Physiol. 2005 Aug;289(2):F442-50
Khan O et al
2005/01/01
PubMed
353 Mankhey RW et al. 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2005 Feb;288(2):F399-405
Mankhey RW et al
2005/01/01
PubMed
354 Lee DL et al. Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats. Am. J. Physiol. Renal Physiol. 2005 Jan;288(1):F82-90
Lee DL et al
2005/01/01
PubMed
355 Dey A et al. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes. Res. 2004 Aug;12(8):1278-89
Dey A et al
2004/01/01
PubMed
356 Lane PH et al. Dissociation of renal TGF-beta and hypertrophy in female rats with diabetes mellitus. Am. J. Physiol. Renal Physiol. 2004 Nov;287(5):F1011-20
Lane PH et al
2004/01/01
PubMed
357 Takahashi K et al. Upregulation of H(+)-peptide cotransporter PEPT2 in rat remnant kidney. Am. J. Physiol. Renal Physiol. 2001 Dec;281(6):F1109-16
Takahashi K et al
2001/01/01
PubMed
358 Dijoseph JF et al. Kidney dysfunction in the arthritic rat. Int. J. Immunopharmacol. 1993 Nov;15(8):933-41
Dijoseph JF et al
1993/01/01
PubMed
359 Cohen MP et al. Treatment with acarbose, an alpha-glucosidase inhibitor, reduces increased albumin excretion in streptozotocin-diabetic rats. Gen. Pharmacol. 1995 Oct;26(6):1355-61
Cohen MP et al
1995/01/01
PubMed
360 Kanemoto N et al. Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler. Nat Commun 2019 05;10(1):2172
Kanemoto N et al
2019/01/01
PubMed
361 Kikuchi K et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun 2019 04;10(1):1835
Kikuchi K et al
2019/01/01
PubMed
362 Hartmann C et al. Angiotensin II-induced hypertension increases the mutant frequency in rat kidney. Arch. Toxicol. 2019 07;93(7):2045-2055
Hartmann C et al
2019/01/01
PubMed
363 Beraldo JI et al. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease. Int J Mol Sci 2019 Apr;20(8)
Beraldo JI et al
2019/01/01
PubMed
364 Koritzinsky EH et al. Circadian variation in the release of small extracellular vesicles can be normalized by vesicle number or TSG101. Am. J. Physiol. Renal Physiol. 2019 11;317(5):F1098-F1110
Koritzinsky EH et al
2019/01/01
PubMed
365 Jain J et al. Effect of sex on glomerular filtration rate in programmed rats by prenatal dexamethasone. Physiol Rep 2019 07;7(12):e14154
Jain J et al
2019/01/01
PubMed
366 Romero MJ et al. Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2016 Feb;113(7):1895-900
Romero MJ et al
2016/01/01
PubMed
367 Li Z et al. Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin. Kidney Int. 2005 Dec;68(6):2766-72
Li Z et al
2005/01/01
PubMed
368 Biederman JI et al. Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes. Kidney Int. 2005 Feb;67(2):554-65
Biederman JI et al
2005/01/01
PubMed
369 Figarola JL et al. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia 2003 Aug;46(8):1140-52
Figarola JL et al
2003/01/01
PubMed
370 Zhang L et al. C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/β-catenin and ERK signaling in streptozocin-induced diabetic nephropathy. FASEB J. 2019 05;33(5):6551-6563
Zhang L et al
2019/01/01
PubMed
371 Choi R et al. Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. Exp. Mol. Med. 2011 Dec;43(12):676-83
Choi R et al
2011/01/01
PubMed
372 Figarola JL et al. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats. Ann. N. Y. Acad. Sci. 2005 Jun;1043:767-76
Figarola JL et al
2005/01/01
PubMed
373 Lee ES et al. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrol. Dial. Transplant. 2016 Mar;31(3):391-400
Lee ES et al
2016/01/01
PubMed
374 Vaziri ND et al. Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol. Dial. Transplant. 2010 Nov;25(11):3525-34
Vaziri ND et al
2010/01/01
PubMed
375 Garg P et al. Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol. Cell. Biol. 2007 Dec;27(24):8698-712
Garg P et al
2007/01/01
PubMed
376 Ding XQ et al. Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206. Mol Nutr Food Res 2015 Dec;59(12):2355-70
Ding XQ et al
2015/01/01
PubMed
377 Wang D et al. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats. Sci Rep 2017 08;7(1):9793
Wang D et al
2017/01/01
PubMed
378 Wagner MC et al. Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1. J. Biol. Chem. 2008 Dec;283(51):35579-89
Wagner MC et al
2008/01/01
PubMed
379 Siddiqui I et al. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy. Transplantation 2006 Aug;82(3):406-14
Siddiqui I et al
2006/01/01
PubMed
380 Chakrabarti R et al. Preventive effects of benfotiamine in chronic diabetic complications. J Diabetes Investig 2011 Apr;2(2):123-31
Chakrabarti R et al
2011/01/01
PubMed
381 Portik-Dobos V et al. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 Feb;290(2):R435-41
Portik-Dobos V et al
2006/01/01
PubMed
382 Katakura M et al. Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. Molecules 2014 Mar;19(3):3247-63
Katakura M et al
2014/01/01
PubMed
383 Lee ES et al. Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice. PLoS ONE 2017;12(6):e0179221
Lee ES et al
2017/01/01
PubMed
384 Luo WM et al. Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling. PLoS ONE 2015;10(12):e0145130
Luo WM et al
2015/01/01
PubMed
385 Dixon A et al. Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy. Am. J. Nephrol. 2007;27(2):120-8
Dixon A et al
2007/01/01
PubMed
386 He J et al. Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy. Metab Syndr Relat Disord 2017 09;15(7):344-353
He J et al
2017/01/01
PubMed
387 Zhang YJ et al. Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney. Pharmacology 2013;92(5-6):245-56
Zhang YJ et al
2013/01/01
PubMed
388 Figarola JL et al. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors. Diabetes Metab. Res. Rev. ;21(6):533-44
Figarola JL et al
PubMed
389 Ow CPC et al. Absence of renal hypoxia in the subacute phase of severe renal ischemia reperfusion injury. Am. J. Physiol. Renal Physiol. 2018 Aug;
Ow CPC et al
2018/01/01
PubMed
390 Kim EY et al. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling. Biochim. Biophys. Acta 2015 Oct;1853(10 Pt A):2610-20
Kim EY et al
2015/01/01
PubMed
391 Hashimoto M et al. Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model. Med Gas Res 2011 Nov;1(1):26
Hashimoto M et al
2011/01/01
PubMed
392 Bai Y et al. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney. Am. J. Physiol. Renal Physiol. 2007 Mar;292(3):F974-80
Bai Y et al
2007/01/01
PubMed
393 Kang JS et al. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Sci Rep 2019 05;9(1):7679
Kang JS et al
2019/01/01
PubMed
394 Mima A et al. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes 2008 Jun;57(6):1712-22
Mima A et al
2008/01/01
PubMed
395 Awad AS et al. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 2011 May;79(10):1090-8
Awad AS et al
2011/01/01
PubMed
396 Mima A et al. Activation of Src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis. PLoS ONE 2011 Mar;6(3):e17929
Mima A et al
2011/01/01
PubMed
397 Mima A et al. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio 2018 04;8(4):664-670
Mima A et al
2018/01/01
PubMed
398 Khan AH et al. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Front Pharmacol 2014;5:216
Khan AH et al
2014/01/01
PubMed
399 Hye Khan MA et al. Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats. Am. J. Hypertens. 2014 Aug;27(8):1087-95
Hye Khan MA et al
2014/01/01
PubMed
400 Brinson KN et al. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013 Oct;305(7):R701-10
Brinson KN et al
2013/01/01
PubMed
401 Hye Khan MA et al. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat. Cardiovasc Drugs Ther 2014 Aug;28(4):313-22
Hye Khan MA et al
2014/01/01
PubMed
402 Katary MM et al. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels. Prostaglandins Other Lipid Mediat. 2017 09;132:3-11
Katary MM et al
2017/01/01
PubMed
403 Hye Khan MA et al. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat. 2016 09;125:40-7
Hye Khan MA et al
2016/01/01
PubMed
404 Nagasawa T et al. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clin. Exp. Pharmacol. Physiol. 2012 May;39(5):454-61
Nagasawa T et al
2012/01/01
PubMed
405 Imig JD et al. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp. Biol. Med. (Maywood) 2012 Dec;237(12):1402-12
Imig JD et al
2012/01/01
PubMed
406 Maile LA et al. Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats. J Diabetes Res 2014;2014:421827
Maile LA et al
2014/01/01
PubMed
407 Elsherbiny NM et al. Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib. J. Physiol. Biochem. 2015 Dec;71(4):635-48
Elsherbiny NM et al
2015/01/01
PubMed
408 Tan CY et al. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy. Nephron 2015;129(2):109-27
Tan CY et al
2015/01/01
PubMed
409 Elmarakby AA et al. Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Int J Hypertens 2012;2012:957235
Elmarakby AA et al
2012/01/01
PubMed
410 Elmarakby AA et al. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2012 Apr;302(7):F791-800
Elmarakby AA et al
2012/01/01
PubMed
  • No.: 1
  • 文献情報:
    Venkatesha S et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 2006 Jun;12(6):642-9
    Venkatesha S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Shimazaki T et al. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology 2002 Jan;35(1):199-208
    Shimazaki T et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Choi WI et al. Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am. J. Respir. Crit. Care Med. 2003 Jun;167(12):1627-32
    Choi WI et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Little MA et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005 Sep;106(6):2050-8
    Little MA et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Koura T et al. Investigation of albumin-synthesizing ability in rat cirrhotic liver-derived hepatocytes using primary hepatocyte culture. J. Hepatol. 1999 Aug;31(2):293-9
    Koura T et al
    1999/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Holwerda KM et al. Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. J. Am. Soc. Nephrol. 2014 Apr;25(4):717-25
    Holwerda KM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Nakano D et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J. Am. Soc. Nephrol. 2012 Nov;23(11):1847-56
    Nakano D et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Salmon AH et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J. Am. Soc. Nephrol. 2012 Aug;23(8):1339-50
    Salmon AH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Vassiliadis J et al. Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling. J. Am. Soc. Nephrol. 2011 Aug;22(8):1453-61
    Vassiliadis J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Shcheglova T et al. Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy. J. Am. Soc. Nephrol. 2009 May;20(5):1012-9
    Shcheglova T et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Russo LM et al. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 2009 Mar;20(3):489-94
    Russo LM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Kim JJ et al. Differential expression of nephrin according to glomerular size in early diabetic kidney disease. J. Am. Soc. Nephrol. 2007 Aug;18(8):2303-10
    Kim JJ et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    M旦ller CC et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J. Am. Soc. Nephrol. 2007 Jan;18(1):29-36
    M旦ller CC et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ostendorf T et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J. Am. Soc. Nephrol. 2006 Apr;17(4):1054-62
    Ostendorf T et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Little MA et al. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J. Am. Soc. Nephrol. 2006 Jan;17(1):160-9
    Little MA et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Zhao X et al. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J. Am. Soc. Nephrol. 2004 May;15(5):1244-53
    Zhao X et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kang SW et al. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J. Am. Soc. Nephrol. 2003 Dec;14(12):3178-87
    Kang SW et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Ostendorf T et al. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2003 Sep;14(9):2237-47
    Ostendorf T et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lee GT et al. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J. Am. Soc. Nephrol. 2003 Mar;14(3):709-20
    Lee GT et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Suga S et al. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms. J. Am. Soc. Nephrol. 2003 Feb;14(2):397-406
    Suga S et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    de Vriese AS et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 2001 May;12(5):993-1000
    de Vriese AS et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Seto M et al. Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis. J. Am. Soc. Nephrol. 1998 Aug;9(8):1367-76
    Seto M et al
    1998/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Morita Y et al. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J. Am. Soc. Nephrol. 1997 Sep;8(9):1363-72
    Morita Y et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Vora JP et al. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J. Am. Soc. Nephrol. 1996 Jan;7(1):113-7
    Vora JP et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Moskowitz DW et al. Effect of epidermal growth factor in the rat 5/6 renal ablation model. J. Am. Soc. Nephrol. 1992 Nov;3(5):1113-8
    Moskowitz DW et al
    1992/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Tagawa A et al. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Diabetes 2016 Mar;65(3):755-67
    Tagawa A et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Ibrahim AS et al. Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 2011 Apr;60(4):1122-33
    Ibrahim AS et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Takiyama Y et al. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1α expression and oxygen metabolism. Diabetes 2011 Mar;60(3):981-92
    Takiyama Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Scalia R et al. Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain. Diabetes 2007 Jul;56(7):1842-9
    Scalia R et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Russo LM et al. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Diabetes 2007 Feb;56(2):380-8
    Russo LM et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Isshiki K et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 2000 Jun;49(6):1022-32
    Isshiki K et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Dooley D et al. Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis. Kidney Int. 2018 11;94(5):926-936
    Dooley D et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Desideri S et al. A novel assay provides sensitive measurement of physiologically relevant changes in albumin permeability in isolated human and rodent glomeruli. Kidney Int. 2018 05;93(5):1086-1097
    Desideri S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Burlaka I et al. Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease. Kidney Int. 2016 07;90(1):135-48
    Burlaka I et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Cassis P et al. Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury. Kidney Int. 2012 May;81(9):903-18
    Cassis P et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Komers R et al. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int. 2011 Feb;79(4):432-42
    Komers R et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Lee SC et al. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int. 2009 Oct;76(8):838-48
    Lee SC et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Zhou H et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int. 2008 Sep;74(5):613-21
    Zhou H et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Tao Y et al. VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int. 2007 Dec;72(11):1358-66
    Tao Y et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Yoo TH et al. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 2007 May;71(10):1019-27
    Yoo TH et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Riazi S et al. 17-beta Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters. Kidney Int. 2006 Feb;69(3):471-80
    Riazi S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Dai T et al. Glucose and diabetes: effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton. Kidney Int. 2006 Mar;69(5):806-14
    Dai T et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Bhatti F et al. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005 Apr;67(4):1371-80
    Bhatti F et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Milovanceva-Popovska M et al. R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury. Kidney Int. 2005 Apr;67(4):1362-70
    Milovanceva-Popovska M et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Xu ZG et al. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli. Kidney Int. 2005 Mar;67(3):944-52
    Xu ZG et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Horiba N et al. Gene expression variance based on random sequencing in rat remnant kidney. Kidney Int. 2004 Jul;66(1):29-45
    Horiba N et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Kalantarinia K et al. Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 2003 Oct;64(4):1208-13
    Kalantarinia K et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Riser BL et al. Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report. Kidney Int. 2003 Aug;64(2):451-8
    Riser BL et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Blasi ER et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003 May;63(5):1791-800
    Blasi ER et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Ji L et al. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int. 2002 Aug;62(2):514-24
    Ji L et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Braun C et al. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat. Kidney Int. 2002 Jun;61(6):2149-56
    Braun C et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Tofovic SP et al. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats. Kidney Int. 2002 Apr;61(4):1433-44
    Tofovic SP et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Takeuchi A et al. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate. Kidney Int. 2001 Sep;60(3):1058-68
    Takeuchi A et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Kang SW et al. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy. Kidney Int. 2001 Apr;59(4):1354-62
    Kang SW et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Richards RJ et al. Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats. Kidney Int. 2001 Jan;59(1):37-43
    Richards RJ et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Hirschberg R et al. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 1993 Feb;43(2):387-97
    Hirschberg R et al
    1993/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Xu Q et al. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension 2008 Apr;51(4):1218-24
    Xu Q et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Li Z et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 2007 Oct;50(4):686-92
    Li Z et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Elmarakby AA et al. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 2006 Mar;47(3):557-62
    Elmarakby AA et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Zhao X et al. Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension 2003 Oct;42(4):775-80
    Zhao X et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Matsuoka H et al. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994 Jun;23(6 Pt 2):971-5
    Matsuoka H et al
    1994/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Saleh MA et al. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Diabetologia 2011 Apr;54(4):979-88
    Saleh MA et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Kuwabara A et al. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia 2010 Sep;53(9):2056-65
    Kuwabara A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Figarola JL et al. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia 2008 May;51(5):882-91
    Figarola JL et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Ota T et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia 2003 Jun;46(6):843-51
    Ota T et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Clayton AM et al. Postpartum increases in cerebral edema and inflammation in response to placental ischemia during pregnancy. Brain Behav. Immun. 2018 05;70:376-389
    Clayton AM et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Yamashita H et al. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat. Metab. Clin. Exp. 2002 Apr;51(4):403-8
    Yamashita H et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Ushida T et al. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model. Free Radic. Biol. Med. 2016 12;101:524-533
    Ushida T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Wang W et al. Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. Free Radic. Biol. Med. 2015 Jun;83:214-26
    Wang W et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Queisser N et al. Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo. Free Radic. Biol. Med. 2013 Jan;54:17-25
    Queisser N et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Nilsson UA et al. The fungal nephrotoxin orellanine simultaneously increases oxidative stress and down-regulates cellular defenses. Free Radic. Biol. Med. 2008 Apr;44(8):1562-9
    Nilsson UA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Menne J et al. Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers. FASEB J. 2006 May;20(7):994-6
    Menne J et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Komers R et al. Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes. Br. J. Pharmacol. 2016 09;173(17):2573-88
    Komers R et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Shimizu S et al. Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney. Br. J. Pharmacol. 2011 May;163(2):272-82
    Shimizu S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Sena CM et al. Metformin restores endothelial function in aorta of diabetic rats. Br. J. Pharmacol. 2011 May;163(2):424-37
    Sena CM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Kuno Y et al. Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats. Br. J. Pharmacol. 2011 Mar;162(6):1389-400
    Kuno Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Sena CM et al. Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br. J. Pharmacol. 2008 Mar;153(5):894-906
    Sena CM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Shibata T et al. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br. J. Pharmacol. 2000 Jun;130(3):495-504
    Shibata T et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Hueper K et al. Magnetic resonance diffusion tensor imaging for evaluation of histopathological changes in a rat model of diabetic nephropathy. Invest Radiol 2012 Jul;47(7):430-7
    Hueper K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Wang B et al. Berberine Improved Aldo-Induced Podocyte Injury via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress Pathways both In Vivo and In Vitro. Cell. Physiol. Biochem. 2016;39(1):217-28
    Wang B et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Yang M et al. Connexin 43 is involved in aldosterone-induced podocyte injury. Cell. Physiol. Biochem. 2014;34(5):1652-62
    Yang M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Hye Khan MA et al. Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy. Clin. Sci. 2016 Apr;130(8):587-99
    Hye Khan MA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Olearczyk JJ et al. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clin. Sci. 2009 Jan;116(1):61-70
    Olearczyk JJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Dey A et al. Rofecoxib decreases renal injury in obese Zucker rats. Clin. Sci. 2004 Dec;107(6):561-70
    Dey A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Komers R et al. Renal p38 MAP kinase activity in experimental diabetes. Lab. Invest. 2007 Jun;87(6):548-58
    Komers R et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Mima A et al. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Lab. Invest. 2006 Sep;86(9):927-39
    Mima A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Matsubara T et al. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab. Invest. 2006 Apr;86(4):357-68
    Matsubara T et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Dias LD et al. Renal denervation in an animal model of diabetes and hypertension: impact on the autonomic nervous system and nephropathy. Cardiovasc Diabetol 2011 Apr;10:33
    Dias LD et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Kim EY et al. Trpc6 inactivation confers protection in a model of severe nephrosis in rats. J. Mol. Med. 2018 07;96(7):631-644
    Kim EY et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Benipal B et al. Influence of renal compensatory hypertrophy on mitochondrial energetics and redox status. Biochem. Pharmacol. 2011 Jan;81(2):295-303
    Benipal B et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Shevalye H et al. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model. Biochem. Pharmacol. 2010 Apr;79(7):1007-14
    Shevalye H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Nakagawa S et al. mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats. Biochem. Pharmacol. 2010 Jan;79(1):67-76
    Nakagawa S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Yokoo S et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem. Pharmacol. 2007 Aug;74(3):477-87
    Yokoo S et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Zhao X et al. Albumin induces CD44 expression in glomerular parietal epithelial cells by activating extracellular signal-regulated kinase 1/2 pathway. J. Cell. Physiol. 2019 05;234(5):7224-7235
    Zhao X et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Peixoto EB et al. Reduced LRP6 expression and increase in the interaction of GSK3β with p53 contribute to podocyte apoptosis in diabetes mellitus and are prevented by green tea. J. Nutr. Biochem. 2015 Apr;26(4):416-30
    Peixoto EB et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Papadimitriou A et al. Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFβ-1 signaling. J. Nutr. Biochem. 2014 Jul;25(7):773-84
    Papadimitriou A et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Tost探es RM et al. Perfusion of 3D encapsulated hepatocytes--a synergistic effect enhancing long-term functionality in bioreactors. Biotechnol. Bioeng. 2011 Jan;108(1):41-9
    Tost探es RM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Sena CM et al. Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol. Res. 2012 May;65(5):497-506
    Sena CM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Paeng J et al. The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions. Nephrol. Dial. Transplant. 2017 01;32(1):61-72
    Paeng J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Lee EY et al. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes. Nephrol. Dial. Transplant. 2012 Nov;27(11):4069-79
    Lee EY et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Jung DS et al. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease. Nephrol. Dial. Transplant. 2012 Jan;27(1):259-66
    Jung DS et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Furuichi K et al. Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrol. Dial. Transplant. 2011 Oct;26(10):3124-31
    Furuichi K et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Nagasu H et al. Renal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats. Nephrol. Dial. Transplant. 2010 Sep;25(9):2889-98
    Nagasu H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Lee SH et al. Effects of an oral adsorbent on oxidative stress and fibronectin expression in experimental diabetic nephropathy. Nephrol. Dial. Transplant. 2010 Jul;25(7):2134-41
    Lee SH et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Fujii H et al. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol. Dial. Transplant. 2009 Jul;24(7):2089-95
    Fujii H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Xu ZG et al. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Nephrol. Dial. Transplant. 2009 Jun;24(6):1744-52
    Xu ZG et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Shibata R et al. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Nephrol. Dial. Transplant. 2009 Apr;24(4):1162-9
    Shibata R et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Satoh M et al. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol. Dial. Transplant. 2008 Dec;23(12):3806-13
    Satoh M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Nakamura S et al. Pyridoxal phosphate prevents progression of diabetic nephropathy. Nephrol. Dial. Transplant. 2007 Aug;22(8):2165-74
    Nakamura S et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Boor P et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol. Dial. Transplant. 2007 May;22(5):1323-31
    Boor P et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Datta PK et al. Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis. Nephrol. Dial. Transplant. 2006 Jan;21(1):51-7
    Datta PK et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Suzuki H et al. Glomerular hyperfiltration and hypertrophy in the rat hypoplastic kidney as a model of oligomeganephronic disease. Nephrol. Dial. Transplant. 2005 Jul;20(7):1362-9
    Suzuki H et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Xu ZG et al. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. Nephrol. Dial. Transplant. 2005 Mar;20(3):524-31
    Xu ZG et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Drel VR et al. Poly(Adenosine 5-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. Endocrinology 2009 Dec;150(12):5273-83
    Drel VR et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Siragy HM et al. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats. Endocrinology 2003 Jun;144(6):2229-33
    Siragy HM et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Lane PH. 5-thio-D-glucose elevates renal transforming growth factor beta-1 at a dose that does not prevent streptozocine diabetes in rats. Endocrinology 2000 Sep;141(9):3337-42
    Lane PH
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Um JE et al. Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions. Sci Rep 2017 08;7(1):8490
    Um JE et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    de Oliveira AA et al. Sustained kidney biochemical derangement in treated experimental diabetes: a clue to metabolic memory. Sci Rep 2017 01;7:40544
    de Oliveira AA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Al-Ani B et al. Changes in urinary metabolomic profile during relapsing renal vasculitis. Sci Rep 2016 12;6:38074
    Al-Ani B et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Ueno Y et al. Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J. Nutr. 2002 May;132(5):897-900
    Ueno Y et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Guo QY et al. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2011 Apr;300(4):E708-16
    Guo QY et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Anderson RL et al. Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat. Am. J. Physiol. Endocrinol. Metab. 2010 Dec;299(6):E959-67
    Anderson RL et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Reinwald S et al. Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models. Am. J. Physiol. Endocrinol. Metab. 2009 Apr;296(4):E765-74
    Reinwald S et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Chen S et al. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am. J. Physiol. Endocrinol. Metab. 2003 Jun;284(6):E1089-97
    Chen S et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Brands MW et al. Decreased cardiac output at the onset of diabetes: renal mechanisms and peripheral vasoconstriction. Am. J. Physiol. Endocrinol. Metab. 2000 May;278(5):E917-24
    Brands MW et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Goto S et al. 22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes. Bone 2015 May;74:153-9
    Goto S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Fujii H et al. Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. Bone 2008 Feb;42(2):372-9
    Fujii H et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Garg P et al. Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. J. Biol. Chem. 2010 Jul;285(29):22676-88
    Garg P et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Nagai K et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 2003 May;278(20):18229-34
    Nagai K et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Kohzuki M et al. Renal-protective effect of non-depressor dose of cicletanine in streptozotocin diabetic rats. J. Hypertens. 1999 May;17(5):695-700
    Kohzuki M et al
    1999/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Detsika MG et al. Heme Oxygenase 1 Up-Regulates Glomerular Decay Accelerating Factor Expression and Minimizes Complement Deposition and Injury. Am. J. Pathol. 2016 11;186(11):2833-2845
    Detsika MG et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Ojima A et al. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression
    Ojima A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Little MA et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am. J. Pathol. 2009 Apr;174(4):1212-20
    Little MA et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Socha MJ et al. Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am. J. Pathol. 2007 Oct;171(4):1104-12
    Socha MJ et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    Makibayashi K et al. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am. J. Pathol. 2001 May;158(5):1733-41
    Makibayashi K et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Yanagita M et al. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am. J. Pathol. 2001 Apr;158(4):1423-32
    Yanagita M et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 137
  • 文献情報:
    Nomura A et al. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am. J. Pathol. 1997 Aug;151(2):539-47
    Nomura A et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 138
  • 文献情報:
    Ebenezer PJ et al. Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) 2009 Nov;17(11):1994-2002
    Ebenezer PJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 139
  • 文献情報:
    Akahori H et al. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression. J. Pharmacol. Exp. Ther. 2005 Aug;314(2):514-21
    Akahori H et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 140
  • 文献情報:
    Aleo MD et al. Model development and analysis of tenidap-induced proteinuria in the rat. J. Pharmacol. Exp. Ther. 1996 Dec;279(3):1318-26
    Aleo MD et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 141
  • 文献情報:
    Lee SH et al. Podocyte hypertrophy precedes apoptosis under experimental diabetic conditions. Apoptosis 2015 Aug;20(8):1056-71
    Lee SH et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 142
  • 文献情報:
    Paeng J et al. Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions. Apoptosis 2014 Dec;19(12):1678-90
    Paeng J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 143
  • 文献情報:
    Kwak SJ et al. Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions. Apoptosis 2011 May;16(5):478-90
    Kwak SJ et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 144
  • 文献情報:
    Nussler AK et al. The suitability of hepatocyte culture models to study various aspects of drug metabolism. ALTEX 2001;18(2):91-101
    Nussler AK et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 145
  • 文献情報:
    Poon R et al. Short-term oral toxicity of three biodiesels and an ultra-low sulfur diesel in male rats. Food Chem. Toxicol. 2009 Jul;47(7):1416-24
    Poon R et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 146
  • 文献情報:
    Poon R et al. Effects of three biodiesels and a low sulfur diesel in male rats--a pilot 4-week oral study. Food Chem. Toxicol. 2007 Oct;45(10):1830-7
    Poon R et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 147
  • 文献情報:
    Koch M et al. Effects of everolimus on cellular and humoral immune processes leading to chronic allograft nephropathy in a rat model with sensitized recipients. Transplantation 2007 Feb;83(4):498-505
    Koch M et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 148
  • 文献情報:
    Koch M et al. Adoptive transfer of primed CD4+ T-lymphocytes induces pattern of chronic allograft nephropathy in a nude rat model. Transplantation 2005 Apr;79(7):753-61
    Koch M et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 149
  • 文献情報:
    Yamashita T et al. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats. Diabetes Res. Clin. Pract. 2002 Sep;57(3):149-61
    Yamashita T et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 150
  • 文献情報:
    Whitney JL et al. Growth hormone exacerbates diabetic renal damage in male but not female rats. Biol Sex Differ 2013;4:12
    Whitney JL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 151
  • 文献情報:
    Meli DN et al. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect. Immun. 2006 Jul;74(7):3890-6
    Meli DN et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 152
  • 文献情報:
    Ishikawa N et al. Genetic effects of blood pressure quantitative trait loci on hypertension-related organ damage: evaluation using multiple congenic strains. Hypertens. Res. 2008 Sep;31(9):1773-9
    Ishikawa N et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 153
  • 文献情報:
    Fujii S et al. Albuminuria, expression of nicotinamide adenine dinucleotide phosphate oxidase and monocyte chemoattractant protein-1 in the renal tubules of hypertensive Dahl salt-sensitive rats. Hypertens. Res. 2007 Oct;30(10):991-8
    Fujii S et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 154
  • 文献情報:
    Kanazawa M et al. Renoprotective effect of angiotensin-converting enzyme inhibitor combined with alpha1-adrenergic antagonist in spontaneously hypertensive rats with renal ablation. Hypertens. Res. 2004 Jul;27(7):509-15
    Kanazawa M et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 155
  • 文献情報:
    Hagiwara M et al. Renal protective role of bradykinin B1 receptor in stroke-prone spontaneously hypertensive rats. Hypertens. Res. 2004 Jun;27(6):399-408
    Hagiwara M et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 156
  • 文献情報:
    Kanazawa M et al. Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation. Hypertens. Res. 200
    Kanazawa M et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 157
  • 文献情報:
    Khan AH et al. Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome. Am. J. Hypertens. 2011 Jul;24(7):816-21
    Khan AH et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 158
  • 文献情報:
    Kohzuki M et al. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension. Am. J. Hypertens. 2000 Mar;13(3):298-306
    Kohzuki M et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 159
  • 文献情報:
    Kitada M et al. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res 2011;2011:9
    Kitada M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 160
  • 文献情報:
    Xu XX et al. Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats. Phytomedicine 2014 May;21(6):815-23
    Xu XX et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 161
  • 文献情報:
    Xu XX et al. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats. Phytomedicine 2013 Jul;20(10):820-7
    Xu XX et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 162
  • 文献情報:
    Su J et al. Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats. Phytomedicine 2010 Mar;17(3-4):254-60
    Su J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 163
  • 文献情報:
    Wu Y et al. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 2008 Oct;44(1):85-91
    Wu Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 164
  • 文献情報:
    Shimizu Y et al. Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2005 Apr;288(4):G664-70
    Shimizu Y et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 165
  • 文献情報:
    Ovcharenko E et al. Peroxisome proliferator-activated receptor alpha and alpha/gamma agonists do not cause impairment in renal function in the rat. Nephron Physiol 2010;115(3):p21-30
    Ovcharenko E et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 166
  • 文献情報:
    Konda T et al. The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome. Nephron Physiol 2005;101(1):p1-13
    Konda T et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 167
  • 文献情報:
    Schaan BD et al. Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes. Nephron Physiol 2005;100(3):p43-50
    Schaan BD et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 168
  • 文献情報:
    Sugimachi M et al. Endogenous endothelin in a rat model of acute colonic mucosal injury. J. Gastroenterol. Hepatol. 2000 Oct;15(10):1125-31
    Sugimachi M et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 169
  • 文献情報:
    Aritomi S et al. The N-type and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-salt diet. Heart Vessels 2010 Nov;25(6):549-55
    Aritomi S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 170
  • 文献情報:
    Cohen MP et al. Amelioration of diabetes-associated abnormalities in the vitreous fluid by an inhibitor of albumin glycation. Invest. Ophthalmol. Vis. Sci. 2008 Nov;49(11):5089-93
    Cohen MP et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 171
  • 文献情報:
    Gu JW et al. Long-term High Salt Diet Causes Hypertension and Decreases Renal Expression of Vascular Endothelial Growth Factor in Sprague-Dawley Rats. J Am Soc Hypertens ;2(4):275-85
    Gu JW et al
  • 備考:
  • 参照:
    PubMed
  • No.: 172
  • 文献情報:
    Ecelbarger CM et al. The effect of chronic candesartan therapy on the metabolic profile and renal tissue cytokine levels in the obese Zucker rat. Mediators Inflamm. 2010;2010:841343
    Ecelbarger CM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 173
  • 文献情報:
    Chen X et al. Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells. Int J Mol Sci 2017 Aug;18(8)
    Chen X et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 174
  • 文献情報:
    Xu HZ et al. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance. Int J Mol Sci 2016 May;17(5)
    Xu HZ et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 175
  • 文献情報:
    Wang K et al. Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys. Am. J. Chin. Med. 2012;40(3):521-36
    Wang K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 176
  • 文献情報:
    Zhang P et al. Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats. Am. J. Chin. Med. 2009;37(2):295-307
    Zhang P et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 177
  • 文献情報:
    Wang MX et al. Nuciferine Alleviates Renal Injury by Inhibiting Inflammatory Responses in Fructose-Fed Rats. J. Agric. Food Chem. 2016 Oct;64(42):7899-7910
    Wang MX et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 178
  • 文献情報:
    Said E et al. Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats. Chem. Biol. Interact. 2018 Feb;281:111-120
    Said E et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 179
  • 文献情報:
    Hamzawy M et al. The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy. Endocrine 2017 Oct;58(1):66-80
    Hamzawy M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 180
  • 文献情報:
    Wang X et al. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther. 2006 Jul;13(14):1097-103
    Wang X et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 181
  • 文献情報:
    Watanabe S et al. Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease. Kidney Blood Press. Res. 2018;43(6):1716-1729
    Watanabe S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 182
  • 文献情報:
    Hu Z et al. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats. Kidney Blood Press. Res. 2012;36(1):85-97
    Hu Z et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 183
  • 文献情報:
    Lecian D et al. Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis. Kidney Blood Press. Res. 2006;29(3):135-43
    Lecian D et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 184
  • 文献情報:
    Sui Y et al. A branched arabinoglucan from Angelica sinensis ameliorates diabetic renal damage in rats. Phytother Res 2019 Mar;33(3):818-831
    Sui Y et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 185
  • 文献情報:
    Doege C et al. Chronic allograft nephropathy in athymic nude rats after adoptive transfer of primed T lymphocytes. Transpl. Int. 2005 Aug;18(8):981-91
    Doege C et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 186
  • 文献情報:
    Paauw ND et al. Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2017 05;312(5):R664-R670
    Paauw ND et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 187
  • 文献情報:
    Gu JW et al. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009 Jul;297(1):R142-8
    Gu JW et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 188
  • 文献情報:
    Abdel-Rahman EM et al. Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008 Nov;295(5):R1473-8
    Abdel-Rahman EM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 189
  • 文献情報:
    Mankhey RW et al. 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007 Feb;292(2):R769-77
    Mankhey RW et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 190
  • 文献情報:
    Gu JW et al. Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 Dec;291(6):R1817-24
    Gu JW et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 191
  • 文献情報:
    Fitzgerald SM et al. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001 Aug;281(2):R547-52
    Fitzgerald SM et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 192
  • 文献情報:
    Zhang M et al. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. J Ethnopharmacol 2012 May;141(1):111-8
    Zhang M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 193
  • 文献情報:
    Liu IM et al. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. J Ethnopharmacol 2009 Jul;124(2):211-8
    Liu IM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 194
  • 文献情報:
    Kitada M et al. A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity. Nutr Metab (Lond) 2018;15:20
    Kitada M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 195
  • 文献情報:
    Tzeng TF et al. Zerumbone, a tropical ginger sesquiterpene, ameliorates streptozotocin-induced diabetic nephropathy in rats by reducing the hyperglycemia-induced inflammatory response. Nutr Metab (Lond) 2013 Oct;10(1):64
    Tzeng TF et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 196
  • 文献情報:
    Mozaffari MS et al. Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab (Lond) 2009 Dec;6:51
    Mozaffari MS et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 197
  • 文献情報:
    Qi XM et al. FK506 ameliorates renal injury in early experimental diabetic rats induced by streptozotocin. Int. Immunopharmacol. 2011 Oct;11(10):1613-9
    Qi XM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 198
  • 文献情報:
    Wu YG et al. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes. Int. Immunopharmacol. 2006 Mar;6(3):445-53
    Wu YG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 199
  • 文献情報:
    Jesmin S et al. Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis. Inflammation 2012 Apr;35(2):484-500
    Jesmin S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 200
  • 文献情報:
    da Silva AS et al. Renal GLUT1 reduction depends on angiotensin-converting enzyme inhibition in diabetic hypertensive rats. Life Sci. 2013 Jul;92(24-26):1174-9
    da Silva AS et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 201
  • 文献情報:
    Ebenezer PJ et al. Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats. Life Sci. 2009 Aug;85(9-10):357-64
    Ebenezer PJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 202
  • 文献情報:
    Siragy HM et al. Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats. Exp. Physiol. 2008 Jul;93(7):817-24
    Siragy HM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 203
  • 文献情報:
    Castoldi G et al. Angiotensin type-2 (AT-2)-receptor activation reduces renal fibrosis in cyclosporine nephropathy: evidence for blood pressure independent effect. Biosci. Rep. 2016 Dec;36(6)
    Castoldi G et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 204
  • 文献情報:
    H旦llriegl W et al. Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis. Eur. J. Pharmacol. 2018 Feb;820:206-216
    H旦llriegl W et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 205
  • 文献情報:
    Kang ES et al. Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur. J. Pharmacol. 2008 Jan;579(1-3):418-25
    Kang ES et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 206
  • 文献情報:
    Saito M et al. N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy. Eur. J. Pharmacol. 2006 Aug;544(1-3):132-7
    Saito M et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 207
  • 文献情報:
    Granitzny A et al. Maintenance of high quality rat precision cut liver slices during culture to study hepatotoxic responses: Acetaminophen as a model compound. Toxicol In Vitro 2017 Aug;42:200-213
    Granitzny A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 208
  • 文献情報:
    Leite SB et al. Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: Improved in vitro models for toxicological applications. Toxicol In Vitro 2011 Jun;25(4):825-32
    Leite SB et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 209
  • 文献情報:
    Niu HS et al. Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats. Drug Des Devel Ther 2016;10:971-8
    Niu HS et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 210
  • 文献情報:
    Mori Y et al. Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus. Drug Des Devel Ther 2014;8:
    Mori Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 211
  • 文献情報:
    Fujii H et al. The Vitamin D Receptor Activator Maxacalcitol Provides Cardioprotective Effects in Diabetes Mellitus. Cardiovasc Drugs Ther 2015 Dec;29(6):499-507
    Fujii H et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 212
  • 文献情報:
    Zhao T et al. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats. PLoS ONE 2016;11(1):e0147693
    Zhao T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 213
  • 文献情報:
    Mansuri A et al. Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion. PLoS ONE 2015;10(12):e0146183
    Mansuri A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 214
  • 文献情報:
    Berger RC et al. Renal Effects and Underlying Molecular Mechanisms of Long-Term Salt Content Diets in Spontaneously Hypertensive Rats. PLoS ONE 2015;10(10):e0141288
    Berger RC et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 215
  • 文献情報:
    Kelly KJ et al. Improved Structure and Function in Autosomal Recessive Polycystic Rat Kidneys with Renal Tubular Cell Therapy. PLoS ONE 2015;10(7):e0131677
    Kelly KJ et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 216
  • 文献情報:
    Nair AR et al. A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway. PLoS ONE 2014;9(11):e111976
    Nair AR et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 217
  • 文献情報:
    Gomes CL et al. The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy. PLoS ONE 2014;9(9):e106929
    Gomes CL et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 218
  • 文献情報:
    Di Marco GS et al. Circulating endothelial progenitor cells in kidney transplant patients. PLoS ONE 2011;6(9):e24046
    Di Marco GS et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 219
  • 文献情報:
    Yokoyama M et al. Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Nutr Res 2010 Mar;30(3):217-25
    Yokoyama M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 220
  • 文献情報:
    Flynn ER et al. C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat. J. Diabetes Complicat. ;27(6):538-47
    Flynn ER et al
  • 備考:
  • 参照:
    PubMed
  • No.: 221
  • 文献情報:
    Chen X et al. Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model. J Diabetes Res 2018;2018:8968573
    Chen X et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 222
  • 文献情報:
    He Y et al. Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model. J Diabetes Res 2016;2016:4157313
    He Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 223
  • 文献情報:
    Sayed AA. Ferulsinaic acid attenuation of diabetic nephropathy. Eur. J. Clin. Invest. 2013 Jan;43(1):56-63
    Sayed AA
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 224
  • 文献情報:
    Xin HG et al. Consumption of hydrogen-rich water alleviates renal injury in spontaneous hypertensive rats. Mol. Cell. Biochem. 2014 Jul;392(1-2):117-24
    Xin HG et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 225
  • 文献情報:
    Okada S et al. Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy. Mol. Cell. Biochem. 2008 Aug;315(1-2):169-77
    Okada S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 226
  • 文献情報:
    Qi XM et al. FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats. Inflamm. Res. 2016 Feb;65(2):103-14
    Qi XM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 227
  • 文献情報:
    Wu YG et al. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats. Inflamm. Res. 2006 May;55(5):192-9
    Wu YG et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 228
  • 文献情報:
    Castoldi G et al. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Am. J. Nephrol. 2013;37(1):65-73
    Castoldi G et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 229
  • 文献情報:
    Goto S et al. Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes. Am. J. Nephrol. 2011;34(3):281-90
    Goto S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 230
  • 文献情報:
    Setti G et al. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes. Am. J. Nephrol. 2010;32(5):393-402
    Setti G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 231
  • 文献情報:
    Fujii H et al. Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes. Am. J. Nephrol. 2010;31(4):342-52
    Fujii H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 232
  • 文献情報:
    Whaley-Connell A et al. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury. Am. J. Nephrol. 2008;28(1):67-75
    Whaley-Connell A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 233
  • 文献情報:
    Satoh M et al. In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats. Microcirculation 2010 Feb;17(2):103-12
    Satoh M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 234
  • 文献情報:
    Laflam PF et al. Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats. Pediatr. Nephrol. 2006 Feb;21(2):177-81
    Laflam PF et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 235
  • 文献情報:
    Garin EH et al. Anti-interleukin 8 antibody abolishes effects of lipoid nephrosis cytokine. Pediatr. Nephrol. 1998 Jun;12(5):381-5
    Garin EH et al
    1998/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 236
  • 文献情報:
    Garin EH et al. Effect of interleukin-8 on glomerular sulfated compounds and albuminuria. Pediatr. Nephrol. 1997 Jun;11(3):274-9
    Garin EH et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 237
  • 文献情報:
    Garin EH. Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria. Pediatr. Nephrol. 1995 Oct;9(5):587-93
    Garin EH
    1995/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 238
  • 文献情報:
    Koh JH et al. Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model. Int J Endocrinol 2014;2014:397307
    Koh JH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 239
  • 文献情報:
    Cutler JL et al. Effects of ototopical antihistamine on otitis media in an allergic rat. Laryngoscope 2008 Feb;118(2):283-7
    Cutler JL et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 240
  • 文献情報:
    Tsuda Y et al. Heterotypic cell interactions on a dually patterned surface. Biochem. Biophys. Res. Commun. 2006 Sep;348(3):937-44
    Tsuda Y et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 241
  • 文献情報:
    Huang H et al. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats. J. Sci. Food Agric. 2017 Mar;97(4):1359-1366
    Huang H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 242
  • 文献情報:
    Siddique K et al. Effect of Postnatal Maternal Protein Intake on Prenatal Programming of Hypertension. Reprod Sci 2014 Apr;
    Siddique K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 243
  • 文献情報:
    Zhang W et al. Total glucosides of paeony attenuate renal tubulointerstitial injury in STZ-induced diabetic rats: role of Toll-like receptor 2. J. Pharmacol. Sci. 2014;125(1):59-67
    Zhang W et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 244
  • 文献情報:
    Wu Y et al. Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes. J. Pharmacol. Sci. 2009 Jan;109(1):78-87
    Wu Y et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 245
  • 文献情報:
    Atsaves V et al. Phenotypic characterization of a novel HO-1 depletion model in the rat. Transgenic Res. 2017 02;26(1):51-64
    Atsaves V et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 246
  • 文献情報:
    Hu X et al. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways. Fundam Clin Pharmacol 2017 Feb;31(1):54-63
    Hu X et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 247
  • 文献情報:
    Oh SW et al. Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis. BMC Nephrol 2013 May;14:105
    Oh SW et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 248
  • 文献情報:
    Lu HJ et al. Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways. BMC Complement Altern Med 2014 May;14:156
    Lu HJ et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 249
  • 文献情報:
    Lu HJ et al. Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat. BMC Complement Altern Med 2014 Mar;14:110
    Lu HJ et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 250
  • 文献情報:
    Cutler JL et al. Effects of ototopic steroid and NSAIDS in clearing middle ear effusion in an animal model. Otolaryngol Head Neck Surg 2006 Oct;135(4):585-9
    Cutler JL et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 251
  • 文献情報:
    Sugimoto K et al. Renal protective effect of YM598, a selective endothelin type A receptor antagonist. J. Cardiovasc. Pharmacol. 2004 Nov;44 Suppl 1:S451-4
    Sugimoto K et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 252
  • 文献情報:
    Mozaffari MS et al. Renoprotective effects of chronic candesartan treatment in uninephrectomized rat. J. Cardiovasc. Pharmacol. 2003 Jan;41(1):81-8
    Mozaffari MS et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 253
  • 文献情報:
    Wu Y et al. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. Nephron Exp. Nephrol. 2014;128(1-2):46-56
    Wu Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 254
  • 文献情報:
    Ishiguro K et al. Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy. Nephron Exp. Nephrol. 2008;109(1):e20-8
    Ishiguro K et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 255
  • 文献情報:
    Qi XM et al. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats. Nephron Exp. Nephrol. 2006;104(4):e147-57
    Qi XM et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 256
  • 文献情報:
    Garin EH et al. Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome. Nephron Exp. Nephrol. 2006;102(3-4):e105-12
    Garin EH et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 257
  • 文献情報:
    Furuse Y et al. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats. Nephron Exp. Nephrol. 2004;98(3):e100-8
    Furuse Y et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 258
  • 文献情報:
    Xu HZ et al. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli. J. Nephrol. 2016 Dec;29(6):775-782
    Xu HZ et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 259
  • 文献情報:
    Ogura Y et al. Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats. Redox Rep. 2018 Dec;23(1):153-159
    Ogura Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 260
  • 文献情報:
    Ma Y et al. The renoprotective effect of shichimotsukokato on hypertension-induced renal dysfunction in spontaneously hypertensive rats. J Nat Med 2016 Apr;70(2):152-62
    Ma Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 261
  • 文献情報:
    Zhou L et al. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J Med Food 2012 May;15(5):461-8
    Zhou L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 262
  • 文献情報:
    Atsaves V et al. Glomerular Epithelial Cells-Targeted Heme Oxygenase-1 Over Expression in the Rat: Attenuation of Proteinuria in Secondary But Not Primary Injury. Nephron 2016;133(4):270-8
    Atsaves V et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 263
  • 文献情報:
    Chen S et al. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron 2002 Jan;90(1):86-94
    Chen S et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 264
  • 文献情報:
    Nakashima A et al. Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis. Nephron 1996;73(1):34-40
    Nakashima A et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 265
  • 文献情報:
    Donnelly SM et al. Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat. Biochem. Cell Biol. 1996;74(3):355-62
    Donnelly SM et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 266
  • 文献情報:
    Reisin E et al. Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet. Am. J. Med. Sci. 2009 Oct;338(4):301-9
    Reisin E et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 267
  • 文献情報:
    Liu IM et al. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats. J. Food Sci. 2011 Sep;76(7):H165-74
    Liu IM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 268
  • 文献情報:
    Koch M et al. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection. Transpl. Immunol. 2016 Mar;35:12-7
    Koch M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 269
  • 文献情報:
    Lemke A et al. Rat renal transplant model for mixed acute humoral and cellular rejection: Weak correlation of serum cytokines/chemokines with intragraft changes. Transpl. Immunol. 2015 Oct;33(2):95-102
    Lemke A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 270
  • 文献情報:
    Koch M et al. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transpl. Immunol. 2013 Dec;29(1-4):43-50
    Koch M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 271
  • 文献情報:
    Poehnert D et al. Induction of chronic renal allograft dysfunction in a rat model with complete and exclusive MHC incompatibility. Transpl. Immunol. 2010 Feb;22(3-4):137-43
    Poehnert D et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 272
  • 文献情報:
    Koch M et al. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model. Transpl. Immunol. 2008 Jul;19(3-4):187-91
    Koch M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 273
  • 文献情報:
    Hamzawy M et al. 22-oxacalcitriol prevents acute kidney injury via inhibition of apoptosis and enhancement of autophagy. Clin. Exp. Nephrol. 2019 Jan;23(1):43-55
    Hamzawy M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 274
  • 文献情報:
    Yamada-Obara N et al. Maternal exposure to high-fat and high-fructose diet evokes hypoadiponectinemia and kidney injury in rat offspring. Clin. Exp. Nephrol. 2016 Dec;20(6):853-861
    Yamada-Obara N et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 275
  • 文献情報:
    Kobayashi S et al. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy. Clin. Exp. Nephrol. 2008 Apr;12(2):119-125
    Kobayashi S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 276
  • 文献情報:
    Qusti S et al. The Hypoglycemic and Antioxidant Activity of Cress Seed and Cinnamon on Streptozotocin Induced Diabetes in Male Rats. Evid Based Complement Alternat Med 2016;2016:5614564
    Qusti S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 277
  • 文献情報:
    Al-Malki AL. Oat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B. Evid Based Complement Alternat Med 2013;2013:609745
    Al-Malki AL
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 278
  • 文献情報:
    Lu HJ et al. An Aqueous-Ethanol Extract of Liriope spicata var. prolifera Ameliorates Diabetic Nephropathy through Suppression of Renal Inflammation. Evid Based Complement Alternat Med 2013;2013:201643
    Lu HJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 279
  • 文献情報:
    Al-Malki AL et al. Proanthocyanidin Attenuation of Oxidative Stress and NF- κ B Protects Apolipoprotein E-Deficient Mice against Diabetic Nephropathy. Evid Based Complement Alternat Med 2013;2013:769409
    Al-Malki AL et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 280
  • 文献情報:
    Tzeng TF et al. The Ethanol Extract of Zingiber zerumbet Attenuates Streptozotocin-Induced Diabetic Nephropathy in Rats. Evid Based Complement Alternat Med 2013;2013:340645
    Tzeng TF et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 281
  • 文献情報:
    Sayed AA. Ferulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic Kidney. Evid Based Complement Alternat Med 2012;2012:580104
    Sayed AA
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 282
  • 文献情報:
    Liu IM et al. Beneficial effect of traditional chinese medicinal formula danggui-shaoyao-san on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats. Evid Based Complement Alternat Med 2012;2012:140103
    Liu IM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 283
  • 文献情報:
    Li X et al. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model. Mol Med Rep 2017 Dec;16(6):9393-9400
    Li X et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 284
  • 文献情報:
    Shi H et al. Effects of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro. Mol Med Rep 2016 Jun;13(6):5102-8
    Shi H et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 285
  • 文献情報:
    Namikoshi T et al. High dietary protein intake induces endothelial dysfunction in uninephrectomized rats. Mol Med Rep ;2(3):429-34
    Namikoshi T et al
  • 備考:
  • 参照:
    PubMed
  • No.: 286
  • 文献情報:
    Shimizu K et al. Increased oxidized protein hydrolase activity in serum and urine of diabetic rat models. Biol. Pharm. Bull. 2009 Sep;32(9):1632-5
    Shimizu K et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 287
  • 文献情報:
    Souza MS et al. Reduced cortical renal GLUT1 expression induced by angiotensin-converting enzyme inhibition in diabetic spontaneously hypertensive rats. Braz. J. Med. Biol. Res. 2008 Nov;41(11):960-8
    Souza MS et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 288
  • 文献情報:
    Kitada M et al. Cyclic and intermittent very low-protein diet can have beneficial effects against advanced diabetic nephropathy in Wistar fatty (fa/fa) rats, an animal model of type 2 diabetes and obesity. Nephrology (Carlton) 2017 Dec;22(12):1030-1034
    Kitada M et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 289
  • 文献情報:
    Yanes LL et al. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med 2011 Apr;8(2):103-15
    Yanes LL et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 290
  • 文献情報:
    Ji H et al. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med 2007 Mar;4(1):56-71
    Ji H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 291
  • 文献情報:
    Kim BH et al. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy. Yonsei Med. J. 2016 May;57(3):664-73
    Kim BH et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 292
  • 文献情報:
    Kim DH et al. Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy. Yonsei Med. J. 2012 Nov;53(6):1165-75
    Kim DH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 293
  • 文献情報:
    Neuman RG et al. Glycated albumin: a marker of glycaemic status in rats with experimental diabetes. Lab. Anim. 1994 Jan;28(1):63-9
    Neuman RG et al
    1994/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 294
  • 文献情報:
    Yang J et al. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway. Immunopharmacol Immunotoxicol 2016;38(2):145-52
    Yang J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 295
  • 文献情報:
    Follansbee MH et al. Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats. Pharmacology 1997 May;54(5):241-55
    Follansbee MH et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 296
  • 文献情報:
    Beyer-Mears A et al. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus. Pharmacology 1996 May;52(5):292-302
    Beyer-Mears A et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 297
  • 文献情報:
    Pess担a BS et al. Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat. J Renin Angiotensin Aldosterone Syst 2012 Mar;13(1):56-66
    Pess担a BS et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 298
  • 文献情報:
    Katsuda Y et al. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. Exp. Anim. 2015;64(2):161-9
    Katsuda Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 299
  • 文献情報:
    Kawakami T et al. Protective effect of composite earthworm powder against diabetic complications via increased fibrinolytic function and improvement of lipid metabolism in ZDF rats. Biosci. Biotechnol. Biochem. 2016 Oct;80(10):1980-9
    Kawakami T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 300
  • 文献情報:
    Nakagiri R et al. Small scale rat hepatocyte primary culture with applications for screening hepatoprotective substances. Biosci. Biotechnol. Biochem. 2003 Aug;67(8):1629-35
    Nakagiri R et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 301
  • 文献情報:
    Nickels DA et al. Effect of chronic growth hormone administration on diabetic nephropathy in the rat. Ann. Clin. Lab. Sci. ;23(6):462-8
    Nickels DA et al
  • 備考:
  • 参照:
    PubMed
  • No.: 302
  • 文献情報:
    Tanaka T et al. Thiamine prevents obesity and obesity-associated metabolic disorders in OLETF rats. J. Nutr. Sci. Vitaminol. 2010;56(6):335-46
    Tanaka T et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 303
  • 文献情報:
    Castoldi G et al. Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis. Clin. Exp. Pharmacol. Physiol. 2016 Mar;43(3):335-42
    Castoldi G et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 304
  • 文献情報:
    Yonekura Y et al. Anti-oxidative effect of the β-blocker carvedilol on diabetic nephropathy in non-obese type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 2015 Sep;42(9):972-978
    Yonekura Y et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 305
  • 文献情報:
    Sun SF et al. Renoprotective effect of berberine on type 2 diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2015 Jun;42(6):662-70
    Sun SF et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 306
  • 文献情報:
    Aritomi S et al. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2015 Apr;42(4):344-52
    Aritomi S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 307
  • 文献情報:
    Ling C et al. Ursolic Acid provides kidney protection in diabetic rats. Curr Ther Res Clin Exp 2013 Dec;75:59-63
    Ling C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 308
  • 文献情報:
    Miranda JP et al. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors. Tissue Eng Part C Methods 2010 Dec;16(6):1223-32
    Miranda JP et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 309
  • 文献情報:
    Matavelli LC et al. (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation. Clin. Exp. Pharmacol. Physiol. 2010 Mar;37(3):277-82
    Matavelli LC et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 310
  • 文献情報:
    Miranda JP et al. Towards an extended functional hepatocyte in vitro culture. Tissue Eng Part C Methods 2009 Jun;15(2):157-67
    Miranda JP et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 311
  • 文献情報:
    Sonalker PA et al. Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-2. Clin. Exp. Pharmacol. Physiol. 2008 May;35(5-6):594-600
    Sonalker PA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 312
  • 文献情報:
    Komers R et al. Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats. Clin. Exp. Pharmacol. Physiol. ;34(1-2):36-41
    Komers R et al
  • 備考:
  • 参照:
    PubMed
  • No.: 313
  • 文献情報:
    Itoh Y et al. Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy. Effects of a PGI(2) derivative. Horm. Res. 2001;56(5-6):165-71
    Itoh Y et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 314
  • 文献情報:
    Kim EY et al. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions. Biochem Biophys Rep 2019 Mar;17:139-150
    Kim EY et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 315
  • 文献情報:
    Torres Fernandez ED et al. Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome. J Endocr Soc 2018 Aug;2(8):949-964
    Torres Fernandez ED et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 316
  • 文献情報:
    Cobbs A et al. Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells. Int J Physiol Pathophysiol Pharmacol 2018;10(1):29-38
    Cobbs A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 317
  • 文献情報:
    Kurosaki Y et al. Oxidative stress increases megalin expression in the renal proximal tubules during the normoalbuminuric stage of diabetes mellitus. Am. J. Physiol. Renal Physiol. 2018 03;314(3):F462-F470
    Kurosaki Y et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 318
  • 文献情報:
    Mansuri A et al. Effect of renal denervation on urine angiotensinogen excretion in prenatally programmed rats. Physiol Rep 2017 Nov;5(20)
    Mansuri A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 319
  • 文献情報:
    Yeboah MM et al. The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats. Am. J. Physiol. Renal Physiol. 2016 09;311(3):F576-85
    Yeboah MM et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 320
  • 文献情報:
    Casare FA et al. Renovascular remodeling and renal injury after extended angiotensin II infusion. Am. J. Physiol. Renal Physiol. 2016 06;310(11):F1295-307
    Casare FA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 321
  • 文献情報:
    Lozano G et al. Effect of prenatal programming and postnatal rearing on glomerular filtration rate in adult rats. Am. J. Physiol. Renal Physiol. 2015 Mar;308(5):F411-9
    Lozano G et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 322
  • 文献情報:
    Mittwede PN et al. Oxidative stress contributes to orthopedic trauma-induced acute kidney injury in obese rats. Am. J. Physiol. Renal Physiol. 2015 Jan;308(2):F157-63
    Mittwede PN et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 323
  • 文献情報:
    Papadimitriou A et al. Theobromine increases NAD⁺/Sirt-1 activity and protects the kidney under diabetic conditions. Am. J. Physiol. Renal Physiol. 2015 Feb;308(3):F209-25
    Papadimitriou A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 324
  • 文献情報:
    Arruda-Junior DF et al. Reduced tubular proteinuria in hypertensive rats treated with losartan is associated with higher renal cortical megalin expression. Horm Mol Biol Clin Investig 2014 May;18(2):105-12
    Arruda-Junior DF et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 325
  • 文献情報:
    Castoldi G et al. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats. Am. J. Physiol. Renal Physiol. 2014 Nov;307(10):F1123-31
    Castoldi G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 326
  • 文献情報:
    Mittwede PN et al. A novel experimental model of orthopedic trauma with acute kidney injury in obese Zucker rats. Physiol Rep 2013 Oct;1(5):e00097
    Mittwede PN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 327
  • 文献情報:
    Kelly KJ et al. Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2013 Dec;305(12):F1804-12
    Kelly KJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 328
  • 文献情報:
    Inoue BH et al. Progression of microalbuminuria in SHR is associated with lower expression of critical components of the apical endocytic machinery in the renal proximal tubule. Am. J. Physiol. Renal Physiol. 2013 Jul;305(2):F216-26
    Inoue BH et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 329
  • 文献情報:
    Flynn ER et al. Amlodipine Reduces Inflammation despite Promoting Albuminuria in the Streptozotocin-Induced Diabetic Rat. Nephron Extra 2012 Jan;2(1):205-18
    Flynn ER et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 330
  • 文献情報:
    Sawyer RT et al. Renoprotective effects of C-peptide in the Dahl salt-sensitive rat. Am. J. Physiol. Renal Physiol. 2012 Sep;303(6):F893-9
    Sawyer RT et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 331
  • 文献情報:
    Tamura Y et al. Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. Am. J. Physiol. Renal Physiol. 2012 Aug;303(3):F339-49
    Tamura Y et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 332
  • 文献情報:
    Anderson S et al. 2-Hydroxyestradiol slows progression of experimental polycystic kidney disease. Am. J. Physiol. Renal Physiol. 2012 Mar;302(5):F636-45
    Anderson S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 333
  • 文献情報:
    Ju KD et al. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2012 Mar;302(5):F606-13
    Ju KD et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 334
  • 文献情報:
    Zoja C et al. Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. Am. J. Physiol. Renal Physiol. 2011 Nov;301(5):F1114-23
    Zoja C et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 335
  • 文献情報:
    Zoja C et al. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection. Am. J. Physiol. Renal Physiol. 2010 Nov;299(5):F1203-11
    Zoja C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 336
  • 文献情報:
    Nishihara K et al. Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats. Am. J. Physiol. Renal Physiol. 2010 Apr;298(4):F923-34
    Nishihara K et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 337
  • 文献情報:
    Lee SH et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am. J. Physiol. Renal Physiol. 2009 Nov;297(5):F1381-90
    Lee SH et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 338
  • 文献情報:
    Gagliardini E et al. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am. J. Physiol. Renal Physiol. 2009 Nov;297(5):F1448-56
    Gagliardini E et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 339
  • 文献情報:
    Xu Q et al. Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney. Am. J. Physiol. Renal Physiol. 2009 Aug;297(2):F307-15
    Xu Q et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 340
  • 文献情報:
    Li JJ et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009 Jul;297(1):F200-9
    Li JJ et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 341
  • 文献情報:
    Luo P et al. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009 Mar;296(3):F556-63
    Luo P et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 342
  • 文献情報:
    Elks CM et al. Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F298-305
    Elks CM et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 343
  • 文献情報:
    Garman JH et al. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am. J. Physiol. Renal Physiol. 2009 Feb;296(2):F306-16
    Garman JH et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 344
  • 文献情報:
    Jung DS et al. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells. Am. J. Physiol. Renal Physiol. 2008 Aug;295(2):F595-604
    Jung DS et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 345
  • 文献情報:
    Dominguez JH et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am. J. Physiol. Renal Physiol. 2008 Jan;294(1):F110-9
    Dominguez JH et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 346
  • 文献情報:
    Dixon A et al. 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am. J. Physiol. Renal Physiol. 2007 Nov;293(5):F1678-90
    Dixon A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 347
  • 文献情報:
    Sun J et al. Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats. Am. J. Physiol. Renal Physiol. 2007 Jun;292(6):F1681-90
    Sun J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 348
  • 文献情報:
    Hayden MR et al. Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat. Am. J. Physiol. Renal Physiol. 2007 Feb;292(2):F861-7
    Hayden MR et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 349
  • 文献情報:
    S叩nchez-Lozada LG et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal Physiol. 2007 Jan;292(1):F423-9
    S叩nchez-Lozada LG et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 350
  • 文献情報:
    Whaley-Connell AT et al. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am. J. Physiol. Renal Physiol. 2006 Dec;291(6):F1308-14
    Whaley-Connell AT et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 351
  • 文献情報:
    Karumanchi SA et al. In vivo rat model of preeclampsia. Methods Mol. Med. 2006;122:393-9
    Karumanchi SA et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 352
  • 文献情報:
    Khan O et al. Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone. Am. J. Physiol. Renal Physiol. 2005 Aug;289(2):F442-50
    Khan O et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 353
  • 文献情報:
    Mankhey RW et al. 17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2005 Feb;288(2):F399-405
    Mankhey RW et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 354
  • 文献情報:
    Lee DL et al. Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats. Am. J. Physiol. Renal Physiol. 2005 Jan;288(1):F82-90
    Lee DL et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 355
  • 文献情報:
    Dey A et al. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes. Res. 2004 Aug;12(8):1278-89
    Dey A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 356
  • 文献情報:
    Lane PH et al. Dissociation of renal TGF-beta and hypertrophy in female rats with diabetes mellitus. Am. J. Physiol. Renal Physiol. 2004 Nov;287(5):F1011-20
    Lane PH et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 357
  • 文献情報:
    Takahashi K et al. Upregulation of H(+)-peptide cotransporter PEPT2 in rat remnant kidney. Am. J. Physiol. Renal Physiol. 2001 Dec;281(6):F1109-16
    Takahashi K et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 358
  • 文献情報:
    Dijoseph JF et al. Kidney dysfunction in the arthritic rat. Int. J. Immunopharmacol. 1993 Nov;15(8):933-41
    Dijoseph JF et al
    1993/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 359
  • 文献情報:
    Cohen MP et al. Treatment with acarbose, an alpha-glucosidase inhibitor, reduces increased albumin excretion in streptozotocin-diabetic rats. Gen. Pharmacol. 1995 Oct;26(6):1355-61
    Cohen MP et al
    1995/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 360
  • 文献情報:
    Kanemoto N et al. Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler. Nat Commun 2019 05;10(1):2172
    Kanemoto N et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 361
  • 文献情報:
    Kikuchi K et al. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease. Nat Commun 2019 04;10(1):1835
    Kikuchi K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 362
  • 文献情報:
    Hartmann C et al. Angiotensin II-induced hypertension increases the mutant frequency in rat kidney. Arch. Toxicol. 2019 07;93(7):2045-2055
    Hartmann C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 363
  • 文献情報:
    Beraldo JI et al. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease. Int J Mol Sci 2019 Apr;20(8)
    Beraldo JI et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 364
  • 文献情報:
    Koritzinsky EH et al. Circadian variation in the release of small extracellular vesicles can be normalized by vesicle number or TSG101. Am. J. Physiol. Renal Physiol. 2019 11;317(5):F1098-F1110
    Koritzinsky EH et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 365
  • 文献情報:
    Jain J et al. Effect of sex on glomerular filtration rate in programmed rats by prenatal dexamethasone. Physiol Rep 2019 07;7(12):e14154
    Jain J et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 366
  • 文献情報:
    Romero MJ et al. Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 2016 Feb;113(7):1895-900
    Romero MJ et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 367
  • 文献情報:
    Li Z et al. Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin. Kidney Int. 2005 Dec;68(6):2766-72
    Li Z et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 368
  • 文献情報:
    Biederman JI et al. Effects of sulfonylureas, alpha-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetes. Kidney Int. 2005 Feb;67(2):554-65
    Biederman JI et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 369
  • 文献情報:
    Figarola JL et al. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia 2003 Aug;46(8):1140-52
    Figarola JL et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 370
  • 文献情報:
    Zhang L et al. C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/β-catenin and ERK signaling in streptozocin-induced diabetic nephropathy. FASEB J. 2019 05;33(5):6551-6563
    Zhang L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 371
  • 文献情報:
    Choi R et al. Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. Exp. Mol. Med. 2011 Dec;43(12):676-83
    Choi R et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 372
  • 文献情報:
    Figarola JL et al. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats. Ann. N. Y. Acad. Sci. 2005 Jun;1043:767-76
    Figarola JL et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 373
  • 文献情報:
    Lee ES et al. Oleanolic acid and N-acetylcysteine ameliorate diabetic nephropathy through reduction of oxidative stress and endoplasmic reticulum stress in a type 2 diabetic rat model. Nephrol. Dial. Transplant. 2016 Mar;31(3):391-400
    Lee ES et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 374
  • 文献情報:
    Vaziri ND et al. Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol. Dial. Transplant. 2010 Nov;25(11):3525-34
    Vaziri ND et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 375
  • 文献情報:
    Garg P et al. Neph1 cooperates with nephrin to transduce a signal that induces actin polymerization. Mol. Cell. Biol. 2007 Dec;27(24):8698-712
    Garg P et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 376
  • 文献情報:
    Ding XQ et al. Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206. Mol Nutr Food Res 2015 Dec;59(12):2355-70
    Ding XQ et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 377
  • 文献情報:
    Wang D et al. Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats. Sci Rep 2017 08;7(1):9793
    Wang D et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 378
  • 文献情報:
    Wagner MC et al. Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1. J. Biol. Chem. 2008 Dec;283(51):35579-89
    Wagner MC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 379
  • 文献情報:
    Siddiqui I et al. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy. Transplantation 2006 Aug;82(3):406-14
    Siddiqui I et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 380
  • 文献情報:
    Chakrabarti R et al. Preventive effects of benfotiamine in chronic diabetic complications. J Diabetes Investig 2011 Apr;2(2):123-31
    Chakrabarti R et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 381
  • 文献情報:
    Portik-Dobos V et al. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 Feb;290(2):R435-41
    Portik-Dobos V et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 382
  • 文献情報:
    Katakura M et al. Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. Molecules 2014 Mar;19(3):3247-63
    Katakura M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 383
  • 文献情報:
    Lee ES et al. Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice. PLoS ONE 2017;12(6):e0179221
    Lee ES et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 384
  • 文献情報:
    Luo WM et al. Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling. PLoS ONE 2015;10(12):e0145130
    Luo WM et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 385
  • 文献情報:
    Dixon A et al. Renoprotective effects of a selective estrogen receptor modulator, raloxifene, in an animal model of diabetic nephropathy. Am. J. Nephrol. 2007;27(2):120-8
    Dixon A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 386
  • 文献情報:
    He J et al. Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy. Metab Syndr Relat Disord 2017 09;15(7):344-353
    He J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 387
  • 文献情報:
    Zhang YJ et al. Nicorandil protects against ischaemia-reperfusion injury in newborn rat kidney. Pharmacology 2013;92(5-6):245-56
    Zhang YJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 388
  • 文献情報:
    Figarola JL et al. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors. Diabetes Metab. Res. Rev. ;21(6):533-44
    Figarola JL et al
  • 備考:
  • 参照:
    PubMed
  • No.: 389
  • 文献情報:
    Ow CPC et al. Absence of renal hypoxia in the subacute phase of severe renal ischemia reperfusion injury. Am. J. Physiol. Renal Physiol. 2018 Aug;
    Ow CPC et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 390
  • 文献情報:
    Kim EY et al. Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling. Biochim. Biophys. Acta 2015 Oct;1853(10 Pt A):2610-20
    Kim EY et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 391
  • 文献情報:
    Hashimoto M et al. Effects of hydrogen-rich water on abnormalities in a SHR.Cg-Leprcp/NDmcr rat - a metabolic syndrome rat model. Med Gas Res 2011 Nov;1(1):26
    Hashimoto M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 392
  • 文献情報:
    Bai Y et al. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney. Am. J. Physiol. Renal Physiol. 2007 Mar;292(3):F974-80
    Bai Y et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 393
  • 文献情報:
    Kang JS et al. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease. Sci Rep 2019 05;9(1):7679
    Kang JS et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 394
  • 文献情報:
    Mima A et al. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes 2008 Jun;57(6):1712-22
    Mima A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 395
  • 文献情報:
    Awad AS et al. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 2011 May;79(10):1090-8
    Awad AS et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 396
  • 文献情報:
    Mima A et al. Activation of Src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis. PLoS ONE 2011 Mar;6(3):e17929
    Mima A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 397
  • 文献情報:
    Mima A et al. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio 2018 04;8(4):664-670
    Mima A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 398
  • 文献情報:
    Khan AH et al. Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Front Pharmacol 2014;5:216
    Khan AH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 399
  • 文献情報:
    Hye Khan MA et al. Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats. Am. J. Hypertens. 2014 Aug;27(8):1087-95
    Hye Khan MA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 400
  • 文献情報:
    Brinson KN et al. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013 Oct;305(7):R701-10
    Brinson KN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 401
  • 文献情報:
    Hye Khan MA et al. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat. Cardiovasc Drugs Ther 2014 Aug;28(4):313-22
    Hye Khan MA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 402
  • 文献情報:
    Katary MM et al. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels. Prostaglandins Other Lipid Mediat. 2017 09;132:3-11
    Katary MM et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 403
  • 文献情報:
    Hye Khan MA et al. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat. 2016 09;125:40-7
    Hye Khan MA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 404
  • 文献情報:
    Nagasawa T et al. Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib. Clin. Exp. Pharmacol. Physiol. 2012 May;39(5):454-61
    Nagasawa T et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 405
  • 文献情報:
    Imig JD et al. Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp. Biol. Med. (Maywood) 2012 Dec;237(12):1402-12
    Imig JD et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 406
  • 文献情報:
    Maile LA et al. Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats. J Diabetes Res 2014;2014:421827
    Maile LA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 407
  • 文献情報:
    Elsherbiny NM et al. Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib. J. Physiol. Biochem. 2015 Dec;71(4):635-48
    Elsherbiny NM et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 408
  • 文献情報:
    Tan CY et al. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy. Nephron 2015;129(2):109-27
    Tan CY et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 409
  • 文献情報:
    Elmarakby AA et al. Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Int J Hypertens 2012;2012:957235
    Elmarakby AA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 410
  • 文献情報:
    Elmarakby AA et al. Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2012 Apr;302(7):F791-800
    Elmarakby AA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed